[
  {
    "title": "$100 Invested In Zoetis 5 Years Ago Would Be Worth This Much Today - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/news/24/01/36498367/100-invested-in-zoetis-5-years-ago-would-be-worth-this-much-today",
    "time_published": "20240104T200320",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Zoetis ZTS has outperformed the market over the past 5 years by 4.74% on an annualized basis producing an average annual return of 17.52%. Currently, Zoetis has a market capitalization of $89.06 billion.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_0.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.160819,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.983605",
        "ticker_sentiment_score": "0.387251",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "YearEnder 2023: From P C Chandra Jewellers to Nike; a sneak peek into print ads rolled out this year",
    "url": "https://www.financialexpress.com/business/brandwagon-yearender-2023-from-p-c-chandra-jewellers-to-nike-a-sneak-peek-into-print-ads-rolled-out-this-year-3354844/",
    "time_published": "20240104T024000",
    "authors": [
      "Saptak Bardhan"
    ],
    "summary": "YearEnder 2023: From P C Chandra Jewellers to Nike. a sneak peek into print ads rolled out this year The Financial Express ...",
    "banner_image": "https://www.financialexpress.com/wp-content/uploads/2023/08/My-project-1-2023-08-11T185939.829.jpg",
    "source": "The Financial Express",
    "category_within_source": "n/a",
    "source_domain": "www.financialexpress.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.170502,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.066047",
        "ticker_sentiment_score": "0.276121",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DNTUF",
        "relevance_score": "0.066047",
        "ticker_sentiment_score": "0.026134",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar",
    "url": "https://www.zacks.com/stock/news/2207964/these-2-medical-stocks-could-beat-earnings-why-they-should-be-on-your-radar",
    "time_published": "20240109T232007",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default46.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.316726"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.999996"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.391133,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.369685",
        "ticker_sentiment_score": "0.371647",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "UNH",
        "relevance_score": "0.369685",
        "ticker_sentiment_score": "0.350052",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "GRFS vs. ZTS: Which Stock Is the Better Value Option?",
    "url": "https://www.zacks.com/stock/news/2209634/grfs-vs-zts-which-stock-is-the-better-value-option",
    "time_published": "20240112T164010",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Investors looking for stocks in the Medical - Drugs sector might want to consider either Grifols ( GRFS Quick QuoteGRFS - ) or Zoetis ( ZTS Quick QuoteZTS - ) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default319.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.890401"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.522174,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.701177",
        "ticker_sentiment_score": "0.614499",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "GRFS",
        "relevance_score": "0.757528",
        "ticker_sentiment_score": "0.629398",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "BIIB, ZTS, EXAS: Which \"Strong Buy\" Healthcare Stock is Best?",
    "url": "https://markets.businessinsider.com/news/stocks/biib-zts-exas-which-strong-buy-healthcare-stock-is-best-1032965194",
    "time_published": "20240113T222408",
    "authors": [
      "Tipranks"
    ],
    "summary": "In 2023, the only thing nearly as hot as generative AI technologies like ChatGPT were GLP-1 injections ( weight-loss drugs like Ozempic ) . GLP-1 may not be the most significant healthcare breakthrough of all time, but it certainly represents one of its most profitable in a while.",
    "banner_image": "https://blog.tipranks.com/wp-content/uploads/2024/01/image-341-1024x339.png?utm_source=markets.businessinsider.com&utm_medium=referral",
    "source": "Business Insider",
    "category_within_source": "GoogleRSS",
    "source_domain": "markets.businessinsider.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.752319"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.360215"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.158519"
      }
    ],
    "overall_sentiment_score": 0.213068,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.200688",
        "ticker_sentiment_score": "0.210098",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "EXAS",
        "relevance_score": "0.278109",
        "ticker_sentiment_score": "0.219781",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BIIB",
        "relevance_score": "0.31583",
        "ticker_sentiment_score": "0.198498",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Zoetis  ( NYSE:ZTS )  Stock Rating Lowered by StockNews.com",
    "url": "https://www.defenseworld.net/2024/01/13/zoetis-nysezts-stock-rating-lowered-by-stocknews-com.html",
    "time_published": "20240113T065445",
    "authors": [
      "Defense World Staff"
    ],
    "summary": "Zoetis ( NYSE:ZTS - Get Free Report ) was downgraded by investment analysts at StockNews.com from a \"strong-buy\" rating to a \"buy\" rating in a research report issued on Thursday. Other equities research analysts have also issued research reports about the stock.",
    "banner_image": "https://www.marketbeat.com/logos/zoetis-inc-logo.png?v=20221021133935",
    "source": "Stocknews.com",
    "category_within_source": "n/a",
    "source_domain": "www.defenseworld.net",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "1.0"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.891286"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.244823,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.747616",
        "ticker_sentiment_score": "0.340676",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "JEF",
        "relevance_score": "0.048036",
        "ticker_sentiment_score": "0.061354",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JBARF",
        "relevance_score": "0.095899",
        "ticker_sentiment_score": "0.151583",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MS",
        "relevance_score": "0.095899",
        "ticker_sentiment_score": "0.151583",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Will Zoetis  ( ZTS )  Beat Estimates Again in Its Next Earnings Report?",
    "url": "https://www.zacks.com/stock/news/2210358/will-zoetis-zts-beat-estimates-again-in-its-next-earnings-report",
    "time_published": "20240115T171011",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default359.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.99998"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.333037,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.411848",
        "ticker_sentiment_score": "0.487785",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Companion Animal Health Market to Reach a Valuation of US$ 61.6 Billion by 2033, By Persistence Market Research",
    "url": "https://www.benzinga.com/pressreleases/24/01/g36636060/companion-animal-health-market-to-reach-a-valuation-of-us-61-6-billion-by-2033-by-persistence-mark",
    "time_published": "20240116T110000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "New York, Jan. 16, 2024 ( GLOBE NEWSWIRE ) -- The Companion Animal Health Market encompasses products and services designed to enhance the well-being of companion animals, including dogs, cats, and other pets.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.744043"
      }
    ],
    "overall_sentiment_score": 0.335856,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.020848",
        "ticker_sentiment_score": "0.224943",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BAYZF",
        "relevance_score": "0.020848",
        "ticker_sentiment_score": "0.138599",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "VRBCF",
        "relevance_score": "0.041682",
        "ticker_sentiment_score": "0.240689",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Council Post: Five Emerging Trends In Pet Health Care For 2024 And Beyond",
    "url": "https://www.forbes.com/sites/forbesbusinesscouncil/2024/01/18/five-emerging-trends-in-pet-health-care-for-2024-and-beyond/",
    "time_published": "20240118T133000",
    "authors": [
      "Alexandre Douzet"
    ],
    "summary": "Five Emerging Trends In Pet Health Care For 2024 And Beyond Forbes ...",
    "banner_image": "https://imageio.forbes.com/specials-images/imageserve/65a7ffeaa58671cd1bcb6a5f/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
    "source": "Forbes",
    "category_within_source": "n/a",
    "source_domain": "www.forbes.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.385557,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.035138",
        "ticker_sentiment_score": "0.130682",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TGHI",
        "relevance_score": "0.035138",
        "ticker_sentiment_score": "0.180503",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Sephora and Zoetis Recognized by Catalyst for Improving Gender Representation and Advancing Women",
    "url": "https://www.prnewswire.com/news-releases/sephora-and-zoetis-recognized-by-catalyst-for-improving-gender-representation-and-advancing-women-302037782.html",
    "time_published": "20240118T050100",
    "authors": [
      "Catalyst",
      "Inc."
    ],
    "summary": "2024 Catalyst Award Winners to be Honored at Annual Gender Equity Conference and Dinner NEW YORK, Jan. 18, 2024 /PRNewswire/ -- Sephora and Zoetis have demonstrated the value of diversity, equity, and inclusion efforts to create workplaces that work for women - and for everyone - and will be ...",
    "banner_image": "https://mma.prnewswire.com/media/537493/Catalyst_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.723405"
      }
    ],
    "overall_sentiment_score": 0.409781,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ACN",
        "relevance_score": "0.02692",
        "ticker_sentiment_score": "0.133496",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.289514",
        "ticker_sentiment_score": "0.400981",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "PFE",
        "relevance_score": "0.02692",
        "ticker_sentiment_score": "0.133496",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "4 Magnificent Stocks I'm Done Waiting on a Dip for in 2024 -- but I'm Not Buying Them Hand Over Fist, Either",
    "url": "https://www.fool.com/investing/2024/01/20/4-magnificent-stocks-im-done-waiting-on-a-dip-for/",
    "time_published": "20240120T140200",
    "authors": [
      "Josh Kohn-Lindquist"
    ],
    "summary": "These stocks never seem to go on sale. Here's why I'm buying them anyway.",
    "banner_image": "https://media.ycharts.com/charts/75e15cca8057c753b05db3b830dba722.png",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.977154"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.576289"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.158519"
      }
    ],
    "overall_sentiment_score": 0.277608,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "CELH",
        "relevance_score": "0.310843",
        "ticker_sentiment_score": "0.328377",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.310843",
        "ticker_sentiment_score": "0.207178",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PEP",
        "relevance_score": "0.039878",
        "ticker_sentiment_score": "0.196879",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CTAS",
        "relevance_score": "0.382925",
        "ticker_sentiment_score": "0.290433",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "AMZN",
        "relevance_score": "0.039878",
        "ticker_sentiment_score": "0.237534",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PFE",
        "relevance_score": "0.039878",
        "ticker_sentiment_score": "0.094995",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ROL",
        "relevance_score": "0.273661",
        "ticker_sentiment_score": "0.225276",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "AbbVie Stock Moves With Rising Relative Strength, Still Room To Grow",
    "url": "https://www.investors.com/news/stocks-with-rising-relative-strength-abbvie-3/",
    "time_published": "20240124T160100",
    "authors": [
      "Investor's Business Daily",
      "INVESTOR'S BUSINESS DAILY",
      "GLENN LARKIN"
    ],
    "summary": "AbbVie ( ABBV ) saw a welcome improvement to its Relative Strength ( RS ) Rating on Wednesday, with an increase from 68 to 71. When you're researching the best stocks to buy and watch, keep a close on eye on relative price strength.",
    "banner_image": "https://www.investors.com/wp-content/uploads/2017/05/IRU4.jpg",
    "source": "Investors Business Daily",
    "category_within_source": "n/a",
    "source_domain": "www.investors.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.316726"
      }
    ],
    "overall_sentiment_score": 0.332934,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.254307",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABBV",
        "relevance_score": "0.582526",
        "ticker_sentiment_score": "0.391654",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Stocks With Rising Relative Strength: AbbVie",
    "url": "https://www.investors.com/ibd-data-stories/stocks-with-rising-relative-strength-abbvie-3/",
    "time_published": "20240124T080000",
    "authors": [
      "INVESTOR'S BUSINESS DAILY",
      "Investor's Business Daily"
    ],
    "summary": "AbbVie ( ABBV ) saw a welcome improvement to its Relative Strength ( RS ) Rating on Wednesday, with an increase from 68 to 71. When you're researching the best stocks to buy and watch, keep a close on eye on relative price strength.",
    "banner_image": "https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg",
    "source": "Investors Business Daily",
    "category_within_source": "n/a",
    "source_domain": "www.investors.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.495866"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      }
    ],
    "overall_sentiment_score": 0.329116,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.343279",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABBV",
        "relevance_score": "0.733479",
        "ticker_sentiment_score": "0.48203",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Zoetis  ( NYSE:ZTS )  Upgraded to Strong-Buy at StockNews.com",
    "url": "https://www.defenseworld.net/2024/01/25/zoetis-nysezts-upgraded-to-strong-buy-at-stocknews-com.html",
    "time_published": "20240125T095246",
    "authors": [
      "Defense World Staff"
    ],
    "summary": "StockNews.com upgraded shares of Zoetis ( NYSE:ZTS - Free Report ) from a buy rating to a strong-buy rating in a report issued on Wednesday.",
    "banner_image": "https://www.marketbeat.com/logos/zoetis-inc-logo.png?v=20221021133935",
    "source": "Stocknews.com",
    "category_within_source": "n/a",
    "source_domain": "www.defenseworld.net",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "1.0"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.947132"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.262855,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "NFLX",
        "relevance_score": "0.043264",
        "ticker_sentiment_score": "0.058502",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LOGI",
        "relevance_score": "0.043264",
        "ticker_sentiment_score": "0.058502",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MS",
        "relevance_score": "0.0864",
        "ticker_sentiment_score": "0.15892",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.745397",
        "ticker_sentiment_score": "0.420544",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "JEF",
        "relevance_score": "0.043264",
        "ticker_sentiment_score": "0.070612",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GS",
        "relevance_score": "0.043264",
        "ticker_sentiment_score": "0.070612",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JBARF",
        "relevance_score": "0.0864",
        "ticker_sentiment_score": "0.15892",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "GRFS or ZTS: Which Is the Better Value Stock Right Now?",
    "url": "https://www.zacks.com/stock/news/2217316/grfs-or-zts-which-is-the-better-value-stock-right-now",
    "time_published": "20240129T164011",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "GRFS vs. ZTS: Which Stock Is the Better Value Option?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default99.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.838487"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.505952,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.76367",
        "ticker_sentiment_score": "0.626046",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "GRFS",
        "relevance_score": "0.811755",
        "ticker_sentiment_score": "0.636782",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Paws And Prosperity: Exploring U.S. Pet Services Growth And The Anticipated Surge In Annual Pet Spending From $980 To $1,292 By 2025 - Chewy  ( NYSE:CHWY ) , Amazon.com  ( NASDAQ:AMZN ) ",
    "url": "https://www.benzinga.com/markets/penny-stocks/24/01/36842775/paws-and-prosperity-exploring-u-s-pet-services-growth-and-the-anticipated-surge-in-annual-pe",
    "time_published": "20240130T131136",
    "authors": [
      "Austin DeNoce"
    ],
    "summary": "The number of U.S. homes with pets has been trending upward for decades, with more than 5 million more pets in the U.S. than before the pandemic. Beyond the pandemic-driven boom, the trends continue, driven by changing social dynamics as well as technological advancements.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/30/screenshot_2024-01-30_at_6.40.08_pm.png?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.2"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.2"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.87644"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.2"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.2"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.2"
      }
    ],
    "overall_sentiment_score": 0.366546,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "TGT",
        "relevance_score": "0.067158",
        "ticker_sentiment_score": "0.227958",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "FRPT",
        "relevance_score": "0.067158",
        "ticker_sentiment_score": "0.307691",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "COST",
        "relevance_score": "0.067158",
        "ticker_sentiment_score": "0.227958",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "IVP",
        "relevance_score": "0.166858",
        "ticker_sentiment_score": "0.273671",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MS",
        "relevance_score": "0.067158",
        "ticker_sentiment_score": "0.135379",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PETQ",
        "relevance_score": "0.067158",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CHWY",
        "relevance_score": "0.133841",
        "ticker_sentiment_score": "0.235563",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.067158",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AMZN",
        "relevance_score": "0.067158",
        "ticker_sentiment_score": "0.197737",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PET",
        "relevance_score": "0.166858",
        "ticker_sentiment_score": "0.273671",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TRUP",
        "relevance_score": "0.067158",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMT",
        "relevance_score": "0.067158",
        "ticker_sentiment_score": "0.227958",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Novo Nordisk Stock Just Earned A 92 RS Rating; Gapped Up On Earnings",
    "url": "https://www.investors.com/news/stocks-showing-market-leadership-novo-nordisk-adr-earns-92-rs-rating-2/",
    "time_published": "20240201T191000",
    "authors": [
      "Investor's Business Daily",
      "GLENN LARKIN",
      "INVESTOR'S BUSINESS DAILY"
    ],
    "summary": "Novo Nordisk Stock Just Earned A 92 RS Rating. Gapped Up On Earnings Investor's Business Daily ...",
    "banner_image": "https://www.investors.com/wp-content/uploads/2017/05/IRU6.jpg",
    "source": "Investors Business Daily",
    "category_within_source": "n/a",
    "source_domain": "www.investors.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.614606"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.37797,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.254307",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EOLS",
        "relevance_score": "0.254307",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVO",
        "relevance_score": "0.254307",
        "ticker_sentiment_score": "0.560025",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,100 Today - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/insights/news/24/02/36892583/if-you-invested-1000-in-this-stock-5-years-ago-you-would-have-2-100-today",
    "time_published": "20240201T163016",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Zoetis ZTS has outperformed the market over the past 5 years by 4.24% on an annualized basis producing an average annual return of 16.37%. Currently, Zoetis has a market capitalization of $86.23 billion.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_4.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.160819,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.983605",
        "ticker_sentiment_score": "0.387251",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Zoetis  ( NYSE:ZTS )  Lowered to \"Buy\" at StockNews.com",
    "url": "https://www.defenseworld.net/2024/02/01/zoetis-nysezts-lowered-to-buy-at-stocknews-com.html",
    "time_published": "20240201T062650",
    "authors": [
      "Defense World Staff"
    ],
    "summary": "Zoetis ( NYSE:ZTS - Get Free Report ) was downgraded by stock analysts at StockNews.com from a \"strong-buy\" rating to a \"buy\" rating in a research report issued on Thursday. Other equities research analysts have also issued reports about the stock.",
    "banner_image": "https://www.marketbeat.com/logos/zoetis-inc-logo-1200x675.png?v=20221021133935",
    "source": "Stocknews.com",
    "category_within_source": "n/a",
    "source_domain": "www.defenseworld.net",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "1.0"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.928769"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.274588,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.753355",
        "ticker_sentiment_score": "0.417271",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "JEF",
        "relevance_score": "0.048621",
        "ticker_sentiment_score": "0.090268",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GS",
        "relevance_score": "0.048621",
        "ticker_sentiment_score": "0.090268",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SLFPF",
        "relevance_score": "0.097062",
        "ticker_sentiment_score": "0.173466",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Mallinckrodt Announces Board of Directors and Leadership Updates",
    "url": "https://www.prnewswire.com/news-releases/mallinckrodt-announces-board-of-directors-and-leadership-updates-302052017.html",
    "time_published": "20240202T134500",
    "authors": [
      "Mallinckrodt plc"
    ],
    "summary": "Four Directors Added to Board Bring Seasoned Experience in Pharmaceuticals, Healthcare, Finance and Operations Siggi Olafsson Will Continue as President, CEO and Board Member",
    "banner_image": "https://mma.prnewswire.com/media/167103/mallinckrodt_plc_logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.224346,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZBH",
        "relevance_score": "0.049732",
        "ticker_sentiment_score": "0.077319",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "APNHF",
        "relevance_score": "0.049732",
        "ticker_sentiment_score": "0.077319",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RPTX",
        "relevance_score": "0.049732",
        "ticker_sentiment_score": "0.077319",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MS",
        "relevance_score": "0.049732",
        "ticker_sentiment_score": "0.077319",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FULC",
        "relevance_score": "0.049732",
        "ticker_sentiment_score": "0.077319",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AMRX",
        "relevance_score": "0.049732",
        "ticker_sentiment_score": "0.077319",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AVRO",
        "relevance_score": "0.049732",
        "ticker_sentiment_score": "0.077319",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TCRX",
        "relevance_score": "0.049732",
        "ticker_sentiment_score": "0.077319",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MYGN",
        "relevance_score": "0.049732",
        "ticker_sentiment_score": "0.077319",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.049732",
        "ticker_sentiment_score": "0.077319",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "XOM",
        "relevance_score": "0.049732",
        "ticker_sentiment_score": "0.077319",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.049732",
        "ticker_sentiment_score": "0.077319",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TXMD",
        "relevance_score": "0.049732",
        "ticker_sentiment_score": "0.077319",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Hold That Spinoff Stock: Selling Could Cost You Big",
    "url": "https://www.forbes.com/sites/jimosman/2024/02/04/hold-that-spinoff-stock-selling-could-cost-you-big/",
    "time_published": "20240204T160000",
    "authors": [
      "Jim Osman"
    ],
    "summary": "The legendary investor Peter Lynch once said, \"Invest in what you know.\" Lynch emphasized the importance of understanding the companies or investments you're involved in, suggesting that investors will make better decisions if they invest in industries or companies they're familiar with or have ...",
    "banner_image": "https://imageio.forbes.com/specials-images/imageserve/65beb7ef4281fc77cd49dc20/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
    "source": "Forbes",
    "category_within_source": "n/a",
    "source_domain": "www.forbes.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.2"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.2"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.2"
      },
      {
        "topic": "IPO",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.2"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.999696"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.2"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.905476"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.682689"
      }
    ],
    "overall_sentiment_score": 0.338951,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDLZ",
        "relevance_score": "0.01978",
        "ticker_sentiment_score": "0.069379",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "KNF",
        "relevance_score": "0.079",
        "ticker_sentiment_score": "0.02953",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MO",
        "relevance_score": "0.01978",
        "ticker_sentiment_score": "0.069379",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SNOW",
        "relevance_score": "0.01978",
        "ticker_sentiment_score": "0.021224",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.01978",
        "ticker_sentiment_score": "0.054423",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVS",
        "relevance_score": "0.01978",
        "ticker_sentiment_score": "0.130559",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BROS",
        "relevance_score": "0.01978",
        "ticker_sentiment_score": "0.021224",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PFE",
        "relevance_score": "0.01978",
        "ticker_sentiment_score": "0.069379",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ENOV",
        "relevance_score": "0.039548",
        "ticker_sentiment_score": "0.167857",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "LOVE",
        "relevance_score": "0.01978",
        "ticker_sentiment_score": "0.021224",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.01978",
        "ticker_sentiment_score": "0.069379",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FLEX",
        "relevance_score": "0.01978",
        "ticker_sentiment_score": "0.130559",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TOST",
        "relevance_score": "0.01978",
        "ticker_sentiment_score": "0.021224",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WOR",
        "relevance_score": "0.01978",
        "ticker_sentiment_score": "0.130559",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WS",
        "relevance_score": "0.01978",
        "ticker_sentiment_score": "0.130559",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PM",
        "relevance_score": "0.01978",
        "ticker_sentiment_score": "0.069379",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CXT",
        "relevance_score": "0.079",
        "ticker_sentiment_score": "0.103308",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GE",
        "relevance_score": "0.039548",
        "ticker_sentiment_score": "0.060121",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDU",
        "relevance_score": "0.098659",
        "ticker_sentiment_score": "0.030886",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NXT(EXP20091224)",
        "relevance_score": "0.01978",
        "ticker_sentiment_score": "0.130559",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CRYPTO:NXT",
        "relevance_score": "0.059292",
        "ticker_sentiment_score": "0.101062",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Stocks To Watch: AbbVie Sees RS Rating Jump To 81",
    "url": "https://www.investors.com/ibd-data-stories/stocks-to-watch-abbvie-sees-rs-rating-jump-to-81/",
    "time_published": "20240205T080000",
    "authors": [
      "INVESTOR'S BUSINESS DAILY",
      "Investor's Business Daily"
    ],
    "summary": "AbbVie ( ABBV ) saw a welcome improvement to its Relative Strength ( RS ) Rating on Monday, with an increase from 78 to 81. When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",
    "banner_image": "https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg",
    "source": "Investors Business Daily",
    "category_within_source": "n/a",
    "source_domain": "www.investors.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.389197,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.338582",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABBV",
        "relevance_score": "0.488777",
        "ticker_sentiment_score": "0.730533",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Global Aquaculture Vaccines Market Size is Estimated to Reach USD 791.42 million by 2031, Growing at a CAGR of 8.2%: Straits Research",
    "url": "https://www.benzinga.com/pressreleases/24/02/g36958850/global-aquaculture-vaccines-market-size-is-estimated-to-reach-usd-791-42-million-by-2031-growing-a",
    "time_published": "20240206T154500",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "New York, United States, Feb. 06, 2024 ( GLOBE NEWSWIRE ) -- Antibiotics have been criticized due to antibiotic residues, bacterial drug resistance, and toxicity. Vaccination is now the most effective method for combating bacterial and viral illnesses in sustainable aquaculture.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.234925,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.070621",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "META",
        "relevance_score": "0.035345",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PAHC",
        "relevance_score": "0.035345",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Zoetis  ( ZTS )  Reports Next Week: Wall Street Expects Earnings Growth",
    "url": "https://www.zacks.com/stock/news/2221862/zoetis-zts-reports-next-week-wall-street-expects-earnings-growth",
    "time_published": "20240206T150030",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Zoetis (ZTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default310.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.316726"
      }
    ],
    "overall_sentiment_score": 0.196053,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.299478",
        "ticker_sentiment_score": "0.242451",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Daily Dividend Report: Mastercard, MMM, Gilead, Keurig, Zoetis",
    "url": "https://www.forbes.com/sites/dividendchannel/2024/02/07/daily-dividend-report-mastercard-mmm-gilead-keurig-zoetis/",
    "time_published": "20240207T203625",
    "authors": [
      "Dividend Channel"
    ],
    "summary": "Mastercard today announced that its Board of Directors has declared a quarterly cash dividend of 66 cents per share. The cash dividend will be paid on May 9, 2024 to holders of record of its Class A common stock and Class B common stock as of April 9, 2024.",
    "banner_image": "https://imageio.forbes.com/specials-images/imageserve/62fe40baadccff017f1dbcbd/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
    "source": "Forbes",
    "category_within_source": "n/a",
    "source_domain": "www.forbes.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.995015"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.161666,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.154455",
        "ticker_sentiment_score": "0.054051",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GILD",
        "relevance_score": "0.154455",
        "ticker_sentiment_score": "0.129185",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MA",
        "relevance_score": "0.154455",
        "ticker_sentiment_score": "-0.014519",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "KDP",
        "relevance_score": "0.154455",
        "ticker_sentiment_score": "0.059218",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Will Sage Therapeutics, Inc.  ( SAGE )  Report Negative Earnings Next Week? What You Should Know",
    "url": "https://www.zacks.com/stock/news/2222623/will-sage-therapeutics-inc-sage-report-negative-earnings-next-week-what-you-should-know",
    "time_published": "20240207T150044",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Sage Therapeutics, Inc. (SAGE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default97.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.133368,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.173022",
        "ticker_sentiment_score": "0.047129",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SAGE",
        "relevance_score": "0.256989",
        "ticker_sentiment_score": "0.003972",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Ahead of Zoetis  ( ZTS )  Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics",
    "url": "https://www.zacks.com/stock/news/2223246/ahead-of-zoetis-zts-q4-earnings-get-ready-with-wall-street-estimates-for-key-metrics",
    "time_published": "20240208T141523",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Beyond analysts' top -and-bottom-line estimates for Zoetis (ZTS), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default102.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.972476"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.115368,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.357636",
        "ticker_sentiment_score": "0.212003",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Jim Cramer's week ahead: Earnings from Shopify, Marriott and Wendy's",
    "url": "https://www.cnbc.com/2024/02/09/jim-cramers-week-ahead-earnings-from-shopify-marriott-and-wendys.html",
    "time_published": "20240209T234637",
    "authors": [
      "Julie Coleman"
    ],
    "summary": "CNBC's Jim Cramer on Friday guided investors through next week's Wall Street action.",
    "banner_image": "https://image.cnbcfm.com/api/v1/image/107371903-1707522007MM-A-020924-short.jpg?v=1707522007&w=750&h=422&vtcrop=y",
    "source": "CNBC",
    "category_within_source": "Top News",
    "source_domain": "www.cnbc.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.744043"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.769861"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      }
    ],
    "overall_sentiment_score": 0.183369,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GOOG",
        "relevance_score": "0.158519",
        "ticker_sentiment_score": "0.085024",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "META",
        "relevance_score": "0.079656",
        "ticker_sentiment_score": "-0.091601",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WEN",
        "relevance_score": "0.158519",
        "ticker_sentiment_score": "0.064512",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ANET",
        "relevance_score": "0.079656",
        "ticker_sentiment_score": "0.14042",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TTD",
        "relevance_score": "0.079656",
        "ticker_sentiment_score": "0.069629",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "KHC",
        "relevance_score": "0.079656",
        "ticker_sentiment_score": "-0.081249",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AN",
        "relevance_score": "0.079656",
        "ticker_sentiment_score": "0.200823",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SHOP",
        "relevance_score": "0.158519",
        "ticker_sentiment_score": "0.188293",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "COST",
        "relevance_score": "0.158519",
        "ticker_sentiment_score": "0.23675",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.079656",
        "ticker_sentiment_score": "0.200823",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CDNS",
        "relevance_score": "0.079656",
        "ticker_sentiment_score": "0.14042",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SPLK",
        "relevance_score": "0.079656",
        "ticker_sentiment_score": "-0.081249",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMT",
        "relevance_score": "0.079656",
        "ticker_sentiment_score": "0.07576",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Zoetis  ( ZTS )  to Report Q4 Earnings: What's in the Cards?",
    "url": "https://www.zacks.com/stock/news/2224211/zoetis-zts-to-report-q4-earnings-whats-in-the-cards",
    "time_published": "20240209T155400",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Zoetis' (ZTS) higher companion animal product sales are expected to have driven revenues in the fourth quarter of 2023, partially offset by declining livestock product sales.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/a7/2964.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.99998"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.182136,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.619419",
        "ticker_sentiment_score": "0.34596",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ADMA",
        "relevance_score": "0.149038",
        "ticker_sentiment_score": "0.047836",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BLUE",
        "relevance_score": "0.149038",
        "ticker_sentiment_score": "0.039905",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "How to Find Strong Medical Stocks Slated for Positive Earnings Surprises",
    "url": "https://www.zacks.com/stock/news/2223944/how-to-find-strong-medical-stocks-slated-for-positive-earnings-surprises",
    "time_published": "20240209T135007",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default315.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.99998"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.410754,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.372448",
        "ticker_sentiment_score": "0.388028",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "HCA",
        "relevance_score": "0.314017",
        "ticker_sentiment_score": "0.34198",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Veterinary Molecular Diagnostics Market Set to Surge at 7.9 % CAGR, to Reach USD 1.1 billion by 2031 | Transparency Market Research, Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/02/g37030062/veterinary-molecular-diagnostics-market-set-to-surge-at-7-9-cagr-to-reach-usd-1-1-billion-by-2031-",
    "time_published": "20240209T110216",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Feb. 09, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The veterinary molecular diagnostics industry was worth US$ 543.9 million in 2022. A CAGR of 7.9% is forecasted from 2023 to 2031, resulting in a market size of US$ 1.1 billion by 2031.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.310791,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.035608",
        "ticker_sentiment_score": "0.090663",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GOOG",
        "relevance_score": "0.035608",
        "ticker_sentiment_score": "0.050233",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IDXX",
        "relevance_score": "0.071145",
        "ticker_sentiment_score": "-0.032592",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.106541",
        "ticker_sentiment_score": "0.091759",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.035608",
        "ticker_sentiment_score": "0.319673",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "BioVaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, and Clinical Stage Assets of the Former IMV Inc.",
    "url": "https://www.prnewswire.com/news-releases/biovaxys-acquires-all-intellectual-property-immunotherapeutics-platform-technology-and-clinical-stage-assets-of-the-former-imv-inc-302059809.html",
    "time_published": "20240212T192100",
    "authors": [
      "BioVaxys Technology Corp."
    ],
    "summary": "BioVaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, and Clinical Stage Assets of the ... PR ...",
    "banner_image": "https://mma.prnewswire.com/media/1436186/4541060/BIOVAXYS_Corporate_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.858979"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.316726"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.129747,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.02105",
        "ticker_sentiment_score": "0.014506",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MRCC",
        "relevance_score": "0.02105",
        "ticker_sentiment_score": "0.117238",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PFE",
        "relevance_score": "0.02105",
        "ticker_sentiment_score": "0.014506",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HRZN",
        "relevance_score": "0.063091",
        "ticker_sentiment_score": "0.154132",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "BioVaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, and Clinical Stage Assets of the Former IMV Inc.",
    "url": "https://www.prnewswire.com/news-releases/biovaxys-acquires-all-intellectual-property-immunotherapeutics-platform-technology-and-clinical-stage-assets-of-the-former-imv-inc-302059806.html",
    "time_published": "20240212T191700",
    "authors": [
      "BioVaxys Technology Corp."
    ],
    "summary": "BioVaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, and Clinical Stage Assets of the ... PR ...",
    "banner_image": "https://mma.prnewswire.com/media/1436186/BIOVAXYS_Corporate_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.858979"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.316726"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.129747,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.02105",
        "ticker_sentiment_score": "0.014506",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MRCC",
        "relevance_score": "0.02105",
        "ticker_sentiment_score": "0.117238",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PFE",
        "relevance_score": "0.02105",
        "ticker_sentiment_score": "0.014506",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HRZN",
        "relevance_score": "0.063091",
        "ticker_sentiment_score": "0.154132",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "ZTS: Zoetis  ( ZTS ) : Analyzing Earnings for Potential Gains",
    "url": "https://stocknews.com/news/zts-gsk-abbv-nvo-zoetis-zts-analyzing-earnings-for-potential-gains/",
    "time_published": "20240212T174911",
    "authors": [
      "StockNews.com Staff"
    ],
    "summary": "Zoetis Inc. ( ZTS ) is a leading force in the realm of animal health, specializing in the discovery, development, manufacturing, and global distribution of vital medicines, vaccines, and diagnostic tools.",
    "banner_image": "https://stocknews.com/wp-content/uploads/2023/06/Anushka-Mukherjee_Headshot-2.jpg",
    "source": "Stocknews.com",
    "category_within_source": "n/a",
    "source_domain": "stocknews.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999941"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.990999"
      }
    ],
    "overall_sentiment_score": 0.306689,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.738815",
        "ticker_sentiment_score": "0.45306",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "ABBV",
        "relevance_score": "0.089462",
        "ticker_sentiment_score": "0.064079",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GSK",
        "relevance_score": "0.089462",
        "ticker_sentiment_score": "0.064079",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVO",
        "relevance_score": "0.089462",
        "ticker_sentiment_score": "0.064079",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Drug, Biotech Stocks' Q4 Earnings Due on Feb 13: BIIB, ZTS & INCY",
    "url": "https://www.zacks.com/stock/news/2224700/drug-biotech-stocks-q4-earnings-due-on-feb-13-biib-zts-incy",
    "time_published": "20240212T141600",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Let's take a look at three biotech/drug companies, BIIB, ZTS, and INCY, slated to release quarterly results on Feb 13.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/49/1007.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.192214,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "AZN",
        "relevance_score": "0.055236",
        "ticker_sentiment_score": "-0.030905",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.467081",
        "ticker_sentiment_score": "0.34523",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "INCY",
        "relevance_score": "0.372315",
        "ticker_sentiment_score": "0.051882",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABBV",
        "relevance_score": "0.055236",
        "ticker_sentiment_score": "-0.030905",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ESALF",
        "relevance_score": "0.055236",
        "ticker_sentiment_score": "0.198927",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PFE",
        "relevance_score": "0.055236",
        "ticker_sentiment_score": "-0.030905",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BIIB",
        "relevance_score": "0.322374",
        "ticker_sentiment_score": "0.264359",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SNY",
        "relevance_score": "0.055236",
        "ticker_sentiment_score": "-0.030905",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Zoetis  ( ZTS )  Q4 2023 Earnings Call Transcript",
    "url": "https://www.fool.com/earnings/call-transcripts/2024/02/13/zoetis-zts-q4-2023-earnings-call-transcript/",
    "time_published": "20240213T203016",
    "authors": [
      "Motley Fool Transcribing"
    ],
    "summary": "ZTS earnings call for the period ending December 31, 2023.",
    "banner_image": "https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Economy - Fiscal",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "1.0"
      },
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.300681,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.037361",
        "ticker_sentiment_score": "0.108747",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BCS",
        "relevance_score": "0.004153",
        "ticker_sentiment_score": "0.228364",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BAC",
        "relevance_score": "0.004153",
        "ticker_sentiment_score": "0.228364",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "GS",
        "relevance_score": "0.004153",
        "ticker_sentiment_score": "0.305027",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MS",
        "relevance_score": "0.004153",
        "ticker_sentiment_score": "0.19193",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "FOREX:USD",
        "relevance_score": "0.012458",
        "ticker_sentiment_score": "0.032098",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Markets Tumble, VIX Up 8% On Hot Inflation Data, Dollar, Yields Jump As Traders Unwind Rate Cut Bets: What's Driving Markets Tuesday? - Airbnb  ( NASDAQ:ABNB ) ",
    "url": "https://www.benzinga.com/markets/equities/24/02/37103116/markets-tumble-vix-up-8-on-hot-inflation-data-dollar-yields-jump-as-traders-unwind-rate-cut-bets",
    "time_published": "20240213T191348",
    "authors": [
      "Piero Cingari"
    ],
    "summary": "Wall Street witnessed one of the worst sessions since the beginning of the year, with widespread declines across the board as stocks were hit by the impact of a higher-than-expected inflation report. The Consumer Price Index ( CPI ) rose at a 3.1% annual rate in January, down from December's 3.4% ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/wall-street-storm-shutter3.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.682689"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.99246"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.495866"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.166667"
      }
    ],
    "overall_sentiment_score": -0.104235,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "KO",
        "relevance_score": "0.146469",
        "ticker_sentiment_score": "-0.098744",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WELL",
        "relevance_score": "0.146469",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WM",
        "relevance_score": "0.146469",
        "ticker_sentiment_score": "-0.098744",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DDOG",
        "relevance_score": "0.146469",
        "ticker_sentiment_score": "-0.098744",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MCO",
        "relevance_score": "0.146469",
        "ticker_sentiment_score": "-0.098744",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.146469",
        "ticker_sentiment_score": "-0.098744",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABNB",
        "relevance_score": "0.146469",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IVZ",
        "relevance_score": "0.146469",
        "ticker_sentiment_score": "0.108051",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SSRM",
        "relevance_score": "0.146469",
        "ticker_sentiment_score": "-0.34037",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "AIG",
        "relevance_score": "0.146469",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BIIB",
        "relevance_score": "0.146469",
        "ticker_sentiment_score": "-0.35758",
        "ticker_sentiment_label": "Bearish"
      },
      {
        "ticker": "ECL",
        "relevance_score": "0.146469",
        "ticker_sentiment_score": "-0.098744",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FOREX:USD",
        "relevance_score": "0.146469",
        "ticker_sentiment_score": "-0.033884",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CRYPTO:BTC",
        "relevance_score": "0.146469",
        "ticker_sentiment_score": "0.106324",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Why Is Zoetis Stock Trading Lower Today? - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/02/37102045/animal-health-focused-zoetis-stock-faces-near-term-pressure-analyst-cites-uncertain",
    "time_published": "20240213T182211",
    "authors": [
      "Vandana Singh"
    ],
    "summary": "On Tuesday, Zoetis Inc ZTS reported fourth-quarter 2023 revenue of $2.21 billion, up 8% Y/Y, on both a reported and operational basis, almost in-line with the consensus of $2.19 billion. Net income for the fourth quarter of 2023 was $525 million, or $1.14 per diluted share, an increase of 14% and ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/pets-gb3aed6be4-1920_0.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.918141"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.278306,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.661658",
        "ticker_sentiment_score": "0.2605",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Zoetis'  ( ZTS )  Q4 Earnings Miss Expectations, Sales Beat",
    "url": "https://www.zacks.com/stock/news/2225640/zoetis-zts-q4-earnings-miss-expectations-sales-beat",
    "time_published": "20240213T162200",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Zoetis (ZTS) reports mixed fourth-quarter results, wherein earnings miss estimates while revenues beat the same.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/a7/2964.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999998"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.10442,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.531786",
        "ticker_sentiment_score": "0.242797",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ADMA",
        "relevance_score": "0.283167",
        "ticker_sentiment_score": "0.107263",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IMCR",
        "relevance_score": "0.244109",
        "ticker_sentiment_score": "0.059589",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PBYI",
        "relevance_score": "0.204417",
        "ticker_sentiment_score": "0.103161",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Zoetis  ( ZTS )  Q4 Earnings Lag Estimates",
    "url": "https://www.zacks.com/stock/news/2225279/zoetis-zts-q4-earnings-lag-estimates",
    "time_published": "20240213T131003",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Zoetis (ZTS) delivered earnings and revenue surprises of -6.77% and 1.04%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default360.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999992"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.152936,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.404563",
        "ticker_sentiment_score": "0.157158",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ONCT",
        "relevance_score": "0.209365",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Should You Invest in the iShares U.S. Pharmaceuticals ETF  ( IHE ) ?",
    "url": "https://www.zacks.com/stock/news/2225205/should-you-invest-in-the-ishares-us-pharmaceuticals-etf-ihe",
    "time_published": "20240213T112007",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Sector ETF report for ...",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default7.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.215642,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BLK",
        "relevance_score": "0.068306",
        "ticker_sentiment_score": "0.032068",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LLY",
        "relevance_score": "0.136113",
        "ticker_sentiment_score": "0.064698",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.136113",
        "ticker_sentiment_score": "0.064698",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IVZ",
        "relevance_score": "0.136113",
        "ticker_sentiment_score": "0.044001",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.136113",
        "ticker_sentiment_score": "0.064698",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Zoetis  ( NYSE:ZTS )  Upgraded to \"Strong-Buy\" at StockNews.com",
    "url": "https://www.defenseworld.net/2024/02/13/zoetis-nysezts-upgraded-to-strong-buy-at-stocknews-com-2.html",
    "time_published": "20240213T092644",
    "authors": [
      "Defense World Staff"
    ],
    "summary": "StockNews.com upgraded shares of Zoetis ( NYSE:ZTS - Free Report ) from a buy rating to a strong-buy rating in a report published on Monday. Other research analysts also recently issued reports about the stock.",
    "banner_image": "https://www.marketbeat.com/logos/zoetis-inc-logo.png?v=20221021133935",
    "source": "Stocknews.com",
    "category_within_source": "n/a",
    "source_domain": "www.defenseworld.net",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "1.0"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.31183,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.733479",
        "ticker_sentiment_score": "0.508231",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "SHAK",
        "relevance_score": "0.049221",
        "ticker_sentiment_score": "0.147054",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WEN",
        "relevance_score": "0.049221",
        "ticker_sentiment_score": "0.147054",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JEF",
        "relevance_score": "0.049221",
        "ticker_sentiment_score": "0.071479",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GS",
        "relevance_score": "0.049221",
        "ticker_sentiment_score": "0.071479",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": " ( ZTS )  - Analyzing Zoetis's Short Interest - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/insights/short-sellers/24/02/37135981/zts-analyzing-zoetiss-short-interest",
    "time_published": "20240214T191513",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Zoetis's ZTS short percent of float has risen 6.67% since its last report. The company recently reported that it has 2.96 million shares sold short, which is 0.64% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.41 days to cover their ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.267375,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.224903",
        "ticker_sentiment_score": "0.158881",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "GRFS or ZTS: Which Is the Better Value Stock Right Now?",
    "url": "https://www.zacks.com/stock/news/2226324/grfs-or-zts-which-is-the-better-value-stock-right-now",
    "time_published": "20240214T164011",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "GRFS vs. ZTS: Which Stock Is the Better Value Option?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default141.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.614606"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.505885,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.626443",
        "ticker_sentiment_score": "0.590606",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "GRFS",
        "relevance_score": "0.690822",
        "ticker_sentiment_score": "0.611566",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Company News for Feb 14, 2024",
    "url": "https://www.zacks.com/stock/news/2226118/company-news-for-feb-14-2024",
    "time_published": "20240214T143500",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Companies in The News Are: ...",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/d9/514.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.838487"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.022309,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.595343",
        "ticker_sentiment_score": "0.134238",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HAS",
        "relevance_score": "0.323078",
        "ticker_sentiment_score": "-0.046277",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ECL",
        "relevance_score": "0.595343",
        "ticker_sentiment_score": "0.337382",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MAR",
        "relevance_score": "0.595343",
        "ticker_sentiment_score": "-0.292926",
        "ticker_sentiment_label": "Somewhat-Bearish"
      }
    ]
  },
  {
    "title": "Should You Invest in the SPDR S&P Pharmaceuticals ETF  ( XPH ) ?",
    "url": "https://www.zacks.com/stock/news/2225920/should-you-invest-in-the-spdr-sp-pharmaceuticals-etf-xph",
    "time_published": "20240214T112002",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Sector ETF report for ...",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default271.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.188582,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.126784",
        "ticker_sentiment_score": "0.069436",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "STT",
        "relevance_score": "0.063594",
        "ticker_sentiment_score": "0.031007",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ITCI",
        "relevance_score": "0.126784",
        "ticker_sentiment_score": "0.069436",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ELAN",
        "relevance_score": "0.126784",
        "ticker_sentiment_score": "0.069436",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Is SPDR S&P Pharmaceuticals ETF  ( XPH )  a Strong ETF Right Now?",
    "url": "https://www.zacks.com/stock/news/2226592/is-spdr-sp-pharmaceuticals-etf-xph-a-strong-etf-right-now",
    "time_published": "20240215T112003",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Smart Beta ETF report for ...",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default353.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.999953"
      }
    ],
    "overall_sentiment_score": 0.235728,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.109956",
        "ticker_sentiment_score": "0.058953",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "STT",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.063848",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ITCI",
        "relevance_score": "0.109956",
        "ticker_sentiment_score": "0.058953",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ELAN",
        "relevance_score": "0.109956",
        "ticker_sentiment_score": "0.058953",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Poultry Vaccines Market Set for Strong Growth Trajectory, Fueled by Increased Meat and Egg Production As Per The Business Research Company's Poultry Vaccines Global Market Report 2024",
    "url": "https://www.benzinga.com/pressreleases/24/02/g37265746/poultry-vaccines-market-set-for-strong-growth-trajectory-fueled-by-increased-meat-and-egg-producti",
    "time_published": "20240222T163000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "LONDON, Feb. 22, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Poultry Vaccines Global Market Report 2024, the poultry vaccines market has demonstrated robust growth in recent years and is poised for further expansion.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.273974,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ELAN",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.087999",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.087999",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Elanco Animal Health  ( ELAN )  Q4 2023 Earnings Call Transcript",
    "url": "https://www.fool.com/earnings/call-transcripts/2024/02/26/elanco-animal-health-elan-q4-2023-earnings-call-tr/",
    "time_published": "20240226T191511",
    "authors": [
      "Motley Fool Transcribing"
    ],
    "summary": "ELAN earnings call for the period ending December 31, 2023.",
    "banner_image": "https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "1.0"
      },
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.318102,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "EVR",
        "relevance_score": "0.004252",
        "ticker_sentiment_score": "0.105252",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BCS",
        "relevance_score": "0.004252",
        "ticker_sentiment_score": "0.112063",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BAC",
        "relevance_score": "0.004252",
        "ticker_sentiment_score": "0.203176",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ELAN",
        "relevance_score": "0.008505",
        "ticker_sentiment_score": "0.104893",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MS",
        "relevance_score": "0.004252",
        "ticker_sentiment_score": "0.112063",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.004252",
        "ticker_sentiment_score": "0.029373",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GS",
        "relevance_score": "0.004252",
        "ticker_sentiment_score": "0.327155",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "FOREX:UYU",
        "relevance_score": "0.004252",
        "ticker_sentiment_score": "0.138037",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "1 Magnificent S&P 500 Dividend Stock Down 23% to Buy Right Now",
    "url": "https://www.fool.com/investing/2024/02/26/1-magnificent-sp-500-dividend-stock-down-23-to-buy/",
    "time_published": "20240226T144500",
    "authors": [
      "Josh Kohn-Lindquist"
    ],
    "summary": "Buoyed by megatrends in animal healthcare, this stock makes for an excellent holding in almost any portfolio.",
    "banner_image": "https://media.ycharts.com/charts/9c35732db68395b67c81e7db4656b467.png",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.795202"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.312977,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.72726",
        "ticker_sentiment_score": "0.472177",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "PFE",
        "relevance_score": "0.051441",
        "ticker_sentiment_score": "-0.002998",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Should You Invest in the VanEck Agribusiness ETF  ( MOO ) ?",
    "url": "https://www.zacks.com/stock/news/2231379/should-you-invest-in-the-vaneck-agribusiness-etf-moo",
    "time_published": "20240226T112005",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Sector ETF report for MOO ...",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default276.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.999998"
      }
    ],
    "overall_sentiment_score": 0.140467,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.141726",
        "ticker_sentiment_score": "0.087052",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DE",
        "relevance_score": "0.141726",
        "ticker_sentiment_score": "0.087052",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BAYZF",
        "relevance_score": "0.071145",
        "ticker_sentiment_score": "0.071346",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "The pet drugs vets are now prescribing look a lot more like human medications",
    "url": "https://www.cnbc.com/2024/02/28/new-pet-drugs-are-looking-a-lot-more-like-human-medications.html",
    "time_published": "20240228T133848",
    "authors": [
      "Ian Thomas"
    ],
    "summary": "New drug treatment options are coming for cats and dogs as the divide between animal and human health is starting to narrow.",
    "banner_image": "https://image.cnbcfm.com/api/v1/image/107372982-17078438181707843816-33319440180-1080pnbcnews.jpg?v=1707843818&w=750&h=422&vtcrop=y",
    "source": "CNBC",
    "category_within_source": "Top News",
    "source_domain": "www.cnbc.com",
    "topics": [
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.090748,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.326884",
        "ticker_sentiment_score": "0.073785",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AZN",
        "relevance_score": "0.037387",
        "ticker_sentiment_score": "0.104308",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVO",
        "relevance_score": "0.037387",
        "ticker_sentiment_score": "0.104308",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PFE",
        "relevance_score": "0.111834",
        "ticker_sentiment_score": "0.102873",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Changemakers: How women are remaking the business world on their own terms",
    "url": "https://www.cnbc.com/2024/02/28/cnbc-changemakers-women-remaking-the-business-world-on-their-terms.html",
    "time_published": "20240228T110311",
    "authors": [
      "Julia Boorstin"
    ],
    "summary": "These 50 women leaders are innovating at the largest companies, startups and nonprofits. CNBC spotlights how they are changing the global economy and society.",
    "banner_image": "https://image.cnbcfm.com/api/v1/image/107379485-1709118724717-GettyImages-1347255492.jpg?v=1709118855&w=1920&h=1080",
    "source": "CNBC",
    "category_within_source": "Top News",
    "source_domain": "www.cnbc.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.30002,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "NET",
        "relevance_score": "0.049629",
        "ticker_sentiment_score": "0.091916",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.049629",
        "ticker_sentiment_score": "0.091916",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Elanco Animal Health is Executing on Plan to Deliver for Shareholders",
    "url": "https://www.prnewswire.com/news-releases/elanco-animal-health-is-executing-on-plan-to-deliver-for-shareholders-302076221.html",
    "time_published": "20240229T180800",
    "authors": [
      "Elanco Animal Health"
    ],
    "summary": "Ancora Nominates Director Candidates Despite Elanco's Meaningful Operational Progress and Good Faith Engagement with the Investor",
    "banner_image": "https://mma.prnewswire.com/media/2309278/Elanco_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.796627"
      }
    ],
    "overall_sentiment_score": 0.209925,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "A",
        "relevance_score": "0.02379",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZBH",
        "relevance_score": "0.02379",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "STE",
        "relevance_score": "0.02379",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.02379",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "VRTX",
        "relevance_score": "0.02379",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ENDPQ",
        "relevance_score": "0.02379",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PRGO",
        "relevance_score": "0.02379",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EW",
        "relevance_score": "0.02379",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HOLX",
        "relevance_score": "0.02379",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ELAN",
        "relevance_score": "0.211601",
        "ticker_sentiment_score": "0.230182",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "JAZZ",
        "relevance_score": "0.02379",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.02379",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BAX",
        "relevance_score": "0.02379",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IDXX",
        "relevance_score": "0.02379",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "INCY",
        "relevance_score": "0.02379",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "XRAY",
        "relevance_score": "0.02379",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CRL",
        "relevance_score": "0.02379",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "REGN",
        "relevance_score": "0.02379",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Alliance Trust PLC - Final Results",
    "url": "https://www.globenewswire.com/news-release/2024/03/07/2841939/0/en/Alliance-Trust-PLC-Final-Results.html",
    "time_published": "20240307T070000",
    "authors": [
      "Alliance Trust Plc"
    ],
    "summary": "Alliance Trust PLC ( 'the Company' ) LEI: ...",
    "banner_image": "",
    "source": "GlobeNewswire",
    "category_within_source": "n/a",
    "source_domain": "www.globenewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.2"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.2"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.2"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.99489"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.2"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "1.0"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.2"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.998947"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.310843"
      }
    ],
    "overall_sentiment_score": 0.214049,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "AON",
        "relevance_score": "0.00897",
        "ticker_sentiment_score": "0.11897",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CVS",
        "relevance_score": "0.004485",
        "ticker_sentiment_score": "0.115012",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.013454",
        "ticker_sentiment_score": "0.122866",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FHI",
        "relevance_score": "0.004485",
        "ticker_sentiment_score": "0.103893",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "VPGLF",
        "relevance_score": "0.004485",
        "ticker_sentiment_score": "0.218658",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CMSQF",
        "relevance_score": "0.004485",
        "ticker_sentiment_score": "0.04724",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DEO",
        "relevance_score": "0.017939",
        "ticker_sentiment_score": "0.126008",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MSFT",
        "relevance_score": "0.017939",
        "ticker_sentiment_score": "0.163144",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "YUM",
        "relevance_score": "0.004485",
        "ticker_sentiment_score": "0.103893",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GEN",
        "relevance_score": "0.004485",
        "ticker_sentiment_score": "0.115012",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ROP",
        "relevance_score": "0.004485",
        "ticker_sentiment_score": "0.115012",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TSLA",
        "relevance_score": "0.00897",
        "ticker_sentiment_score": "0.140863",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ELAN",
        "relevance_score": "0.004485",
        "ticker_sentiment_score": "0.115012",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EBCOF",
        "relevance_score": "0.004485",
        "ticker_sentiment_score": "0.053049",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NOW",
        "relevance_score": "0.004485",
        "ticker_sentiment_score": "0.081164",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.004485",
        "ticker_sentiment_score": "0.115012",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "KD",
        "relevance_score": "0.004485",
        "ticker_sentiment_score": "0.053049",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MORN",
        "relevance_score": "0.013454",
        "ticker_sentiment_score": "0.102739",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SWRAY",
        "relevance_score": "0.004485",
        "ticker_sentiment_score": "0.081998",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GE",
        "relevance_score": "0.004485",
        "ticker_sentiment_score": "0.218658",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "FOREX:GBP",
        "relevance_score": "0.004485",
        "ticker_sentiment_score": "0.040901",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FOREX:JPY",
        "relevance_score": "0.004485",
        "ticker_sentiment_score": "0.040901",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Looking Into Zoetis's Recent Short Interest - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/insights/short-sellers/24/03/37561492/looking-into-zoetiss-recent-short-interest",
    "time_published": "20240308T153029",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Zoetis's ZTS short percent of float has risen 6.67% since its last report. The company recently reported that it has 2.96 million shares sold short, which is 0.64% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.41 days to cover their ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.267375,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.224903",
        "ticker_sentiment_score": "0.158881",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Zoetis  ( ZTS )  Down 4.3% Since Last Earnings Report: Can It Rebound?",
    "url": "https://www.zacks.com/stock/news/2240857/zoetis-zts-down-43-since-last-earnings-report-can-it-rebound",
    "time_published": "20240314T153034",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Zoetis (ZTS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default185.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.983605"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.040711,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.53074",
        "ticker_sentiment_score": "0.121914",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Here's How Much $100 Invested In Zoetis 10 Years Ago Would Be Worth Today - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/insights/news/24/03/37824841/heres-how-much-100-invested-in-zoetis-10-years-ago-would-be-worth-today",
    "time_published": "20240319T150041",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Zoetis ZTS has outperformed the market over the past 10 years by 8.7% on an annualized basis producing an average annual return of 19.35%. Currently, Zoetis has a market capitalization of $78.30 billion.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_3.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.238974,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.95919",
        "ticker_sentiment_score": "0.384695",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "ZTS: How To Painlessly Put Together A Profitable POWR Pairs Trade",
    "url": "https://stocknews.com/news/zts-how-to-painlessly-put-together-a-profitable-powr-pairs-trade/",
    "time_published": "20240323T210625",
    "authors": [
      "StockNews.com Staff"
    ],
    "summary": "StockNews.com developed the POWR rating system for stocks several decades ago. It incorporates 118 different factors that identify individual equities that are likely to outperform the overall market. The POWR rating system also uncovers stocks that are poised to underperform.",
    "banner_image": "https://stocknews.com/wp-content/uploads/2024/03/Picture21323.png",
    "source": "Stocknews.com",
    "category_within_source": "n/a",
    "source_domain": "stocknews.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.999365"
      }
    ],
    "overall_sentiment_score": 0.159358,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.539024",
        "ticker_sentiment_score": "0.116478",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Largest Animal Health Firm Zoetis Hit With European Probe Over Possible Breach of Competition Rules Related To Dog Pain Medicine - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/news/large-cap/24/03/37967535/largest-animal-health-firm-zoetis-hit-with-european-probe-over-possible-breach-of-competition-rule",
    "time_published": "20240327T182655",
    "authors": [
      "Vandana Singh"
    ],
    "summary": "The European Commission announced on Tuesday that it has initiated an investigation into whether Zoetis Inc ( NYSE: ZTS hindered the market launch of a competing pain medication for dogs. Zoetis' Librela is the first and only monoclonal antibody medicine approved in Europe to treat pain ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/Dog-Hat-Shutterstock_0.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.126554,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.795859",
        "ticker_sentiment_score": "0.162341",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Here's How Much You Would Have Made Owning Zoetis Stock In The Last 10 Years - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/insights/news/24/03/37990625/heres-how-much-you-would-have-made-owning-zoetis-stock-in-the-last-10-years",
    "time_published": "20240328T173018",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Zoetis ZTS has outperformed the market over the past 10 years by 8.44% on an annualized basis producing an average annual return of 19.17%. Currently, Zoetis has a market capitalization of $78.33 billion.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_1.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.238974,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.95919",
        "ticker_sentiment_score": "0.384695",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Is It Time to Buy the S&P 500's 3 Worst-Performing Stocks of March?",
    "url": "https://www.fool.com/investing/2024/04/01/time-to-buy-sp-500-worst-performing-stocks/",
    "time_published": "20240401T071000",
    "authors": [
      "Jeremy Bowman"
    ],
    "summary": "The S&P 500 rose last month, but these stocks didn't.",
    "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F771120%2Feconomic-crisis-stock-chart-falling-down-business-global-money-bankruptcy.jpg&op=resize&w=700",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.999687"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.25"
      }
    ],
    "overall_sentiment_score": 0.049187,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.459624",
        "ticker_sentiment_score": "-0.064818",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LULU",
        "relevance_score": "0.138863",
        "ticker_sentiment_score": "-0.244924",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "NKE",
        "relevance_score": "0.069697",
        "ticker_sentiment_score": "-0.202216",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "LUV",
        "relevance_score": "0.138863",
        "ticker_sentiment_score": "-0.144516",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FL",
        "relevance_score": "0.069697",
        "ticker_sentiment_score": "-0.202216",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "BA",
        "relevance_score": "0.20698",
        "ticker_sentiment_score": "-0.043006",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "This Is What Whales Are Betting On Zoetis - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/insights/options/24/04/38096936/this-is-what-whales-are-betting-on-zoetis",
    "time_published": "20240404T171553",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Deep-pocketed investors have adopted a bullish approach towards Zoetis ZTS, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.614606"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.316726"
      }
    ],
    "overall_sentiment_score": 0.186264,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.778376",
        "ticker_sentiment_score": "0.305893",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Why Zoetis  ( ZTS )  Dipped More Than Broader Market Today",
    "url": "https://www.zacks.com/stock/news/2252262/why-zoetis-zts-dipped-more-than-broader-market-today",
    "time_published": "20240408T221522",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "The latest trading day saw Zoetis (ZTS) settling at $165.69, representing a -0.1% change from its previous close.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default110.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.928769"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.316726"
      }
    ],
    "overall_sentiment_score": 0.122222,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.535653",
        "ticker_sentiment_score": "0.192433",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "How's AT&T Handling Things?",
    "url": "https://www.fool.com/investing/2024/04/09/hows-att-handling-things/",
    "time_published": "20240409T135106",
    "authors": [
      "Motley Fool Staff"
    ],
    "summary": "We've also got a look at 3M's spinoff, gold prices, and the beef industry.",
    "banner_image": "https://g.foolcdn.com/editorial/images/771772/mfm_01.jpg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.25"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "1.0"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.310843"
      }
    ],
    "overall_sentiment_score": 0.158747,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "PATH",
        "relevance_score": "0.015502",
        "ticker_sentiment_score": "0.027454",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PYPL",
        "relevance_score": "0.007751",
        "ticker_sentiment_score": "0.108536",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SOLV",
        "relevance_score": "0.046482",
        "ticker_sentiment_score": "0.143241",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NRHI",
        "relevance_score": "0.015502",
        "ticker_sentiment_score": "-0.006244",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.023251",
        "ticker_sentiment_score": "0.06323",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "VZ",
        "relevance_score": "0.023251",
        "ticker_sentiment_score": "0.090219",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.023251",
        "ticker_sentiment_score": "0.090942",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MASI",
        "relevance_score": "0.007751",
        "ticker_sentiment_score": "0.048741",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PFE",
        "relevance_score": "0.007751",
        "ticker_sentiment_score": "0.108536",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "T",
        "relevance_score": "0.054218",
        "ticker_sentiment_score": "0.066001",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EBAY",
        "relevance_score": "0.007751",
        "ticker_sentiment_score": "0.108536",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AMD",
        "relevance_score": "0.030998",
        "ticker_sentiment_score": "0.072383",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "KVUE",
        "relevance_score": "0.015502",
        "ticker_sentiment_score": "0.048142",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.007751",
        "ticker_sentiment_score": "0.108536",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FDX",
        "relevance_score": "0.007751",
        "ticker_sentiment_score": "0.059386",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BA",
        "relevance_score": "0.007751",
        "ticker_sentiment_score": "0.073734",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": " ( ZTS )  - Analyzing Zoetis's Short Interest - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/insights/short-sellers/24/04/38183729/zts-analyzing-zoetiss-short-interest",
    "time_published": "20240410T140031",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Zoetis's ZTS short percent of float has fallen 4.88% since its last report. The company recently reported that it has 3.57 million shares sold short, which is 0.78% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.0 days to cover their ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.264538,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.212115",
        "ticker_sentiment_score": "0.081887",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "ZTS, EXAS, AZN: Which Biotech Stock Is the Better Buy?",
    "url": "https://markets.businessinsider.com/news/stocks/zts-exas-azn-which-biotech-stock-is-the-better-buy-1033235096",
    "time_published": "20240410T045746",
    "authors": [
      "Tipranks"
    ],
    "summary": "Despite the market's hot year-to-date run, there's no shortage of affordable stocks that also have impressive growth profiles. In the biotech scene, numerous firms can harness a technological edge to improve various aspects of health and medicine.",
    "banner_image": "https://blog.tipranks.com/wp-content/uploads/2024/04/image-332-1024x372.png?utm_source=markets.businessinsider.com&utm_medium=referral",
    "source": "Business Insider",
    "category_within_source": "GoogleRSS",
    "source_domain": "markets.businessinsider.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.99999"
      }
    ],
    "overall_sentiment_score": 0.21151,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.295867",
        "ticker_sentiment_score": "0.287667",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "AZN",
        "relevance_score": "0.22421",
        "ticker_sentiment_score": "0.319452",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "EXAS",
        "relevance_score": "0.260321",
        "ticker_sentiment_score": "-0.105073",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Zoetis, Inc. Investors: Company Investigated by the Portnoy Law Firm - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/pressreleases/24/04/g38226791/zoetis-inc-investors-company-investigated-by-the-portnoy-law-firm",
    "time_published": "20240412T190633",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, April 12, 2024 ( GLOBE NEWSWIRE ) -- The Portnoy Law Firm advises Zoetis, Inc. ( \"Zoetis\" ) ZTS investors that the firm has initiated an investigation into possible securities fraud and may file ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.10123,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.61135",
        "ticker_sentiment_score": "-0.042985",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Zoetis Inc. and Encourages Investors with Losses to Contact the Firm - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/pressreleases/24/04/g38226200/investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-zoetis-inc-an",
    "time_published": "20240412T182916",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "LOS ANGELES, April 12, 2024 ( GLOBE NEWSWIRE ) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ( \"Zoetis\" or \"the Company\" ) ZTS for violations of the securities laws.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": -0.067115,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.582526",
        "ticker_sentiment_score": "-0.35567",
        "ticker_sentiment_label": "Bearish"
      }
    ]
  },
  {
    "title": "S&P 500 And Dow Jones Sink As Banks Weigh On Indexes",
    "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-sp500-nasdaq-jpmorgan-stock-jpm-bank-earnings/",
    "time_published": "20240412T175500",
    "authors": [
      "Investor's Business Daily",
      "KIMBERLEY KOENIG"
    ],
    "summary": "Stocks worsened in afternoon trading on the stock market today with the major indexes running near lows and falling below key moving averages. Among the losers were several big banks that kicked off earnings season with JPMorgan Chase ( JPM ) , Wells Fargo ( WFC ) and Citigroup ( C ) all ...",
    "banner_image": "https://www.investors.com/wp-content/uploads/2022/05/Stock-bearmarket-05-adobe.jpg",
    "source": "Investors Business Daily",
    "category_within_source": "n/a",
    "source_domain": "www.investors.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.2"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.2"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.2"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.2"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "1.0"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.2"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.972476"
      }
    ],
    "overall_sentiment_score": -0.040787,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "GOOG",
        "relevance_score": "0.058472",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.174167",
        "ticker_sentiment_score": "0.376546",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "ANET",
        "relevance_score": "0.116631",
        "ticker_sentiment_score": "0.003438",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "C",
        "relevance_score": "0.174167",
        "ticker_sentiment_score": "-0.105629",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.174167",
        "ticker_sentiment_score": "-0.091843",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "INTC",
        "relevance_score": "0.174167",
        "ticker_sentiment_score": "-0.041464",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AMD",
        "relevance_score": "0.174167",
        "ticker_sentiment_score": "-0.041464",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.116631",
        "ticker_sentiment_score": "-0.148017",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CPNG",
        "relevance_score": "0.116631",
        "ticker_sentiment_score": "0.052577",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IVZ",
        "relevance_score": "0.058472",
        "ticker_sentiment_score": "-0.084374",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Animal Health Giant Zoetis Stock Crumbles: Possible Side Effect Of Its Pet Arthritis Pain Drugs Sickened Dogs, Cats Why Is Animal Health Giant Zoetis Stock Tumbling On Friday? - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/general/biotech/24/04/38223218/animal-health-giant-zoetis-stock-crumbles-possible-side-effect-of-its-pet-arthritis-pain-drugs-si",
    "time_published": "20240412T153055",
    "authors": [
      "Vandana Singh"
    ],
    "summary": "Zoetis Inc ZTS tumbled to a 52-week low after a media report suggested the company's arthritis shots, Librela and Solensia, could have sickened dogs and cats. Solensia ( frunevetmab ) gained FDA approval in January 2022 for pain associated with osteoarthritis in cats.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/pets-gb3aed6be4-1920_4.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.055752,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.56217",
        "ticker_sentiment_score": "-0.123115",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "SHAREHOLDER ALERT: Zoetis Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/pressreleases/24/04/g38221721/shareholder-alert-zoetis-investigated-by-block-leviton-for-potential-securities-law-violations-inv",
    "time_published": "20240412T143034",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "BOSTON, April 12, 2024 ( GLOBE NEWSWIRE ) -- Block & Leviton is investigating Zoetis, Inc. ZTS for potential securities law violations. Investors who have lost money in their Zoetis, Inc. investment should contact the firm to learn more about how they might recover those losses.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.955357"
      }
    ],
    "overall_sentiment_score": -0.014781,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.546745",
        "ticker_sentiment_score": "-0.027465",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "A Closer Look at Zoetis's Options Market Dynamics - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/insights/options/24/04/38221358/a-closer-look-at-zoetiss-options-market-dynamics",
    "time_published": "20240412T141846",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Deep-pocketed investors have adopted a bullish approach towards Zoetis ZTS, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.495866"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.188651,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.704675",
        "ticker_sentiment_score": "0.342107",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Investigation into Zoetis Underway: Johnson Fistel, LLP Digs into Alleged Securities Law Violations - What Shareholders Need to Know - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/pressreleases/24/04/g38221224/investigation-into-zoetis-underway-johnson-fistel-llp-digs-into-alleged-securities-law-violations-",
    "time_published": "20240412T141310",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "SAN DIEGO, April 12, 2024 ( GLOBE NEWSWIRE ) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of securities laws by Zoetis Inc. ( \"Zoetis\" or \"the Company\" ) ZTS. We are looking into whether the Company or its executives failed to disclose vital ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.918141"
      }
    ],
    "overall_sentiment_score": 0.172462,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.582526",
        "ticker_sentiment_score": "0.127961",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Zoetis Stock Dives On Report Arthritis Shots Sickened Dogs, Cats",
    "url": "https://www.investors.com/news/technology/zoetis-stock-arthritis-shots-librela-solensia/",
    "time_published": "20240412T135500",
    "authors": [
      "ALLISON GATLIN",
      "Investor's Business Daily"
    ],
    "summary": "Zoetis ( ZTS ) stock crumbled Friday after a Wall Street Journal report suggested the company's arthritis shots, Librela and Solensia, could have sickened dogs and cats. The shots, which gained Food and Drug Administration approval in 2022 and 2023, respectively, are the first antibody drugs ...",
    "banner_image": "https://www.investors.com/wp-content/uploads/2019/10/stock-Zoetis-04-shutter.jpg",
    "source": "Investors Business Daily",
    "category_within_source": "n/a",
    "source_domain": "www.investors.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.112756,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.660632",
        "ticker_sentiment_score": "-0.238944",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "DXCM",
        "relevance_score": "0.151539",
        "ticker_sentiment_score": "0.306548",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "ZOETIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Zoetis Inc. on Behalf of Zoetis Stockholders and Encourages Investors to Contact the Firm - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/pressreleases/24/04/g38230594/zoetis-alert-bragar-eagel-squire-p-c-is-investigating-zoetis-inc-on-behalf-of-zoetis-stockholders-",
    "time_published": "20240413T010000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "NEW YORK, April 12, 2024 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Zoetis Inc. ( \"Zoetis\" or the \"Company\" ) ZTS on behalf of Zoetis stockholders.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.684621"
      }
    ],
    "overall_sentiment_score": 0.002454,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.7887",
        "ticker_sentiment_score": "-0.114252",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Zoetis  ( ZTS )  Drops on Report that Arthritis Drugs May Sicken Pets - Hagens Berman - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/pressreleases/24/04/g38230462/zoetis-zts-drops-on-report-that-arthritis-drugs-may-sicken-pets-hagens-berman",
    "time_published": "20240413T002026",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "SAN FRANCISCO, April 12, 2024 ( GLOBE NEWSWIRE ) -- Hagens Berman urges Zoetis Inc. ZTS investors who suffered substantial losses to submit your losses now and persons with knowledge who may be able to assist the investigation to contact its attorneys.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": -0.007355,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.787116",
        "ticker_sentiment_score": "-0.024408",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Zoetis  ( ZTS )  Stock Moves -0.14%: What You Should Know",
    "url": "https://www.zacks.com/stock/news/2255702/zoetis-zts-stock-moves--014-what-you-should-know",
    "time_published": "20240415T221517",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "In the latest trading session, Zoetis (ZTS) closed at $149.77, marking a -0.14% move from the previous day.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default313.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.983783"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.140786,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.613743",
        "ticker_sentiment_score": "0.32293",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Zoetis Inc.  ( ZTS )  - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/pressreleases/24/04/g38259876/kirby-mcinerney-llp-announces-investigation-of-shareholder-claims-against-zoetis-inc-zts",
    "time_published": "20240415T210312",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "NEW YORK, April 15, 2024 ( GLOBE NEWSWIRE ) -- The law firm of Kirby McInerney LLP is investigating potential claims against Zoetis Inc. ( \"Zoetis\" or the \"Company\" ) ZTS. The investigation concerns whether Zoetis and/or certain of its officers have violated the federal securities laws and/or ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.124466,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.82515",
        "ticker_sentiment_score": "0.110531",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Company News for Apr 15, 2024",
    "url": "https://www.zacks.com/stock/news/2255180/company-news-for-apr-15-2024",
    "time_published": "20240415T132800",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Companies In The Article Are:INTC,ZTS,X,NPSCY and ...",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/22/2089.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.077861,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "X",
        "relevance_score": "0.588876",
        "ticker_sentiment_score": "0.541115",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.588876",
        "ticker_sentiment_score": "-0.41068",
        "ticker_sentiment_label": "Bearish"
      },
      {
        "ticker": "PGR",
        "relevance_score": "0.588876",
        "ticker_sentiment_score": "0.335605",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "INTC",
        "relevance_score": "0.588876",
        "ticker_sentiment_score": "-0.087954",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NISTF",
        "relevance_score": "0.318897",
        "ticker_sentiment_score": "0.380259",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Veterinary Artificial Insemination (AI) Market size to grow by USD 1.03 billion from 2022 to 2027, Technavio - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/veterinary-artificial-insemination-ai-market-size-to-grow-by-usd-1-03-billion-from-2022-to-2027--technavio-302115298.html",
    "time_published": "20240415T033600",
    "authors": [],
    "summary": "Veterinary Artificial Insemination ( AI ) Market size to grow by USD 1.03 billion from 2022 to 2027, Technavio PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.302858,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.02695",
        "ticker_sentiment_score": "0.186676",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "AGTEF",
        "relevance_score": "0.02695",
        "ticker_sentiment_score": "0.186676",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Here's How Much You Would Have Made Owning Zoetis Stock In The Last 10 Years - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/insights/news/24/04/38277799/heres-how-much-you-would-have-made-owning-zoetis-stock-in-the-last-10-years",
    "time_published": "20240416T180041",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Zoetis ZTS has outperformed the market over the past 10 years by 7.37% on an annualized basis producing an average annual return of 17.75%. Currently, Zoetis has a market capitalization of $69.99 billion.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_0.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.238974,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.95919",
        "ticker_sentiment_score": "0.384695",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "SHAREHOLDER ALERT: Zoetis Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/pressreleases/24/04/g38340811/shareholder-alert-zoetis-investigated-by-block-leviton-for-potential-securities-law-violations-inv",
    "time_published": "20240419T184356",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "BOSTON, April 19, 2024 ( GLOBE NEWSWIRE ) -- Block & Leviton is investigating Zoetis, Inc. ZTS for potential securities law violations. Investors who have lost money in their Zoetis, Inc. investment should contact the firm to learn more about how they might recover those losses.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.955357"
      }
    ],
    "overall_sentiment_score": -0.014781,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.546745",
        "ticker_sentiment_score": "-0.027465",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/pressreleases/24/04/g38340139/rosen-a-trusted-and-leading-law-firm-encourages-zoetis-inc-investors-to-inquire-about-securities-c",
    "time_published": "20240419T180104",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "NEW YORK, April 19, 2024 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Zoetis Inc. ZTS resulting from allegations that Zoetis may have issued materially misleading business ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.744043"
      }
    ],
    "overall_sentiment_score": 0.177147,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.428632",
        "ticker_sentiment_score": "0.037973",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "META",
        "relevance_score": "0.075161",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Jack Daniels Parent Company, EA, Cognizant Among 6 Stocks That Shine When Nvidia Slips: Analysis - Cognizant Tech Solns  ( NASDAQ:CTSH ) , Cboe Global Markets  ( BATS:CBOE ) ",
    "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38330421/jack-daniels-parent-company-ea-cognizant-among-6-stocks-that-shine-when-nvidia-slip",
    "time_published": "20240419T093145",
    "authors": [
      "Benzinga Neuro"
    ],
    "summary": "Six S&P 500 stocks often experience a surge when shares of Nvidia Corporation NVDA take a dip, an analysis by CNBC revealed. What Happened: The six U.S.-listed stocks that typically see a rise when Nvidia's shares falter include Jack Daniel's distiller Brown-Forman Corporation BF BF, gaming giant ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/04/19/nvidia-chart-shutter2.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.2"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.2"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.2"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.2"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.2"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      }
    ],
    "overall_sentiment_score": 0.153376,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "EVR",
        "relevance_score": "0.088147",
        "ticker_sentiment_score": "0.028814",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.493442",
        "ticker_sentiment_score": "0.050443",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HSIC",
        "relevance_score": "0.175221",
        "ticker_sentiment_score": "0.145327",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BF-A",
        "relevance_score": "0.088147",
        "ticker_sentiment_score": "0.105483",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.175221",
        "ticker_sentiment_score": "0.145327",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CTSH",
        "relevance_score": "0.175221",
        "ticker_sentiment_score": "0.145327",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CBOE",
        "relevance_score": "0.175221",
        "ticker_sentiment_score": "0.145327",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EA",
        "relevance_score": "0.175221",
        "ticker_sentiment_score": "0.145327",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Zoetis  ( ZTS )  Stock Dips While Market Gains: Key Facts",
    "url": "https://www.zacks.com/stock/news/2259683/zoetis-zts-stock-dips-while-market-gains-key-facts",
    "time_published": "20240422T221519",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "In the latest trading session, Zoetis (ZTS) closed at $145.54, marking a -0.66% move from the previous day.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default80.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.95493"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.135248,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.654859",
        "ticker_sentiment_score": "0.268052",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "SAP Announces Q1 2024 Results",
    "url": "https://www.prnewswire.com/news-releases/sap-announces-q1-2024-results-302123716.html",
    "time_published": "20240422T200500",
    "authors": [
      "SAP SE"
    ],
    "summary": "\u2022 Cloud revenue up 24% and up 25% at constant currencies, supported by 32% Cloud ERP Suite revenue growth at constant currencies \u2022 Current cloud backlog of \u20ac14.2 billion, up 27% and up 28% at constant currencies \u2022 IFRS cloud gross profit up 27%, non-IFRS cloud gross profit up 27% and up 28% at ...",
    "banner_image": "https://mma.prnewswire.com/media/1093077/SAP_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.25"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.858979"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Economy - Macro",
        "relevance_score": "0.158519"
      }
    ],
    "overall_sentiment_score": 0.265523,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "NVDA",
        "relevance_score": "0.018187",
        "ticker_sentiment_score": "0.1082",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CWEN",
        "relevance_score": "0.018187",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SAP",
        "relevance_score": "0.534294",
        "ticker_sentiment_score": "0.329061",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "KO",
        "relevance_score": "0.018187",
        "ticker_sentiment_score": "0.083376",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SOHVF",
        "relevance_score": "0.018187",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PUPOF",
        "relevance_score": "0.018187",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CHDN",
        "relevance_score": "0.018187",
        "ticker_sentiment_score": "0.120827",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CURN",
        "relevance_score": "0.018187",
        "ticker_sentiment_score": "0.080684",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FSNUF",
        "relevance_score": "0.018187",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CCEP",
        "relevance_score": "0.018187",
        "ticker_sentiment_score": "0.083376",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CW",
        "relevance_score": "0.018187",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IRWD",
        "relevance_score": "0.018187",
        "ticker_sentiment_score": "0.120827",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SSUMF",
        "relevance_score": "0.018187",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MCO",
        "relevance_score": "0.036365",
        "ticker_sentiment_score": "0.05811",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.018187",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Zoetis  ( ZTS )  Drops on Report that Arthritis Drugs May Sicken Pets - Hagens Berman - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/pressreleases/24/04/g38364210/zoetis-zts-drops-on-report-that-arthritis-drugs-may-sicken-pets-hagens-berman",
    "time_published": "20240422T192054",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "SAN FRANCISCO, April 22, 2024 ( GLOBE NEWSWIRE ) -- Hagens Berman urges Zoetis Inc. ZTS investors who suffered substantial losses to submit your losses now and persons with knowledge who may be able to assist the investigation to contact its attorneys.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": -0.007355,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.787116",
        "ticker_sentiment_score": "-0.024408",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "ROSEN, A TOP RANKED LAW FIRM, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/pressreleases/24/04/g38388120/rosen-a-top-ranked-law-firm-encourages-zoetis-inc-investors-to-inquire-about-securities-class-acti",
    "time_published": "20240423T184937",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "NEW YORK, April 23, 2024 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Zoetis Inc. ZTS resulting from allegations that Zoetis may have issued materially misleading business ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.744043"
      }
    ],
    "overall_sentiment_score": 0.177147,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.428632",
        "ticker_sentiment_score": "0.037973",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "META",
        "relevance_score": "0.075161",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "SAP's Q1 Earnings and Revenues Rise Y/Y on Cloud Strength",
    "url": "https://www.zacks.com/stock/news/2260284/saps-q1-earnings-and-revenues-rise-yy-on-cloud-strength",
    "time_published": "20240423T131700",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "SAP's first-quarter performance benefits from continued strength in its cloud business, especially its Cloud ERP suite.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/ab/1753.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.538269"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.998663"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.25"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      }
    ],
    "overall_sentiment_score": 0.104305,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "CWEN",
        "relevance_score": "0.030799",
        "ticker_sentiment_score": "0.058484",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SAP",
        "relevance_score": "0.536802",
        "ticker_sentiment_score": "0.158434",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SOHVF",
        "relevance_score": "0.030799",
        "ticker_sentiment_score": "0.058484",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PUPOF",
        "relevance_score": "0.030799",
        "ticker_sentiment_score": "0.058484",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CHDN",
        "relevance_score": "0.030799",
        "ticker_sentiment_score": "0.054242",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FSNUF",
        "relevance_score": "0.030799",
        "ticker_sentiment_score": "0.058484",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CW",
        "relevance_score": "0.030799",
        "ticker_sentiment_score": "0.058484",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IRWD",
        "relevance_score": "0.030799",
        "ticker_sentiment_score": "0.054242",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "XM",
        "relevance_score": "0.122737",
        "ticker_sentiment_score": "-0.036057",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SSUMF",
        "relevance_score": "0.030799",
        "ticker_sentiment_score": "0.058484",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.030799",
        "ticker_sentiment_score": "0.058484",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CDNS",
        "relevance_score": "0.15308",
        "ticker_sentiment_score": "0.168503",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CTAS",
        "relevance_score": "0.030799",
        "ticker_sentiment_score": "0.12138",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BLKB",
        "relevance_score": "0.122737",
        "ticker_sentiment_score": "0.139683",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BMI",
        "relevance_score": "0.122737",
        "ticker_sentiment_score": "0.130466",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zoetis Inc. - ZTS - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/pressreleases/24/04/g38408243/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-zoetis-inc-zts",
    "time_published": "20240424T152023",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "NEW YORK, April 24, 2024 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Zoetis Inc. ( \"Zoetis\" or the \"Company\" ) ZTS. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.075674,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.565345",
        "ticker_sentiment_score": "0.017464",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Bragar Eagel & Squire, P.C. Is Investigating Zoetis, and Morgan Stanley and Encourages Investors to Contact the Firm - Morgan Stanley  ( NYSE:MS ) , Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/pressreleases/24/04/g38394222/bragar-eagel-squire-p-c-is-investigating-zoetis-and-morgan-stanley-and-encourages-investors-to-con",
    "time_published": "20240424T010000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "NEW YORK, April 23, 2024 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Zoetis Inc.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.684621"
      }
    ],
    "overall_sentiment_score": 0.002435,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.654016",
        "ticker_sentiment_score": "-0.245557",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "MS",
        "relevance_score": "0.567746",
        "ticker_sentiment_score": "-0.003473",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Zoetis  ( ZTS )  Earnings Expected to Grow: What to Know Ahead of Next Week's Release",
    "url": "https://www.zacks.com/stock/news/2262312/zoetis-zts-earnings-expected-to-grow-what-to-know-ahead-of-next-weeks-release",
    "time_published": "20240425T140211",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Zoetis (ZTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default182.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.316726"
      }
    ],
    "overall_sentiment_score": 0.14482,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.260652",
        "ticker_sentiment_score": "0.151609",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "NBIX",
        "relevance_score": "0.088309",
        "ticker_sentiment_score": "0.040167",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Zoetis  ( ZTS )  to Report Q1 Earnings: What's in the Cards?",
    "url": "https://www.zacks.com/stock/news/2262357/zoetis-zts-to-report-q1-earnings-whats-in-the-cards",
    "time_published": "20240425T140200",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Zoetis' (ZTS) higher companion animal product sales are expected to have driven revenues in the first quarter of 2024 in both the United States and International segments.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/a7/2964.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999813"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.178451,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ALNY",
        "relevance_score": "0.142847",
        "ticker_sentiment_score": "-0.003857",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.564609",
        "ticker_sentiment_score": "0.313217",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BLUE",
        "relevance_score": "0.095517",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SRPT",
        "relevance_score": "0.142847",
        "ticker_sentiment_score": "0.135783",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Behind the Scenes of Zoetis's Latest Options Trends - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/insights/options/24/04/38469405/behind-the-scenes-of-zoetiss-latest-options-trends",
    "time_published": "20240426T193127",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Financial giants have made a conspicuous bullish move on Zoetis. Our analysis of options history for Zoetis ZTS revealed 14 unusual trades. Delving into the details, we found 57% of traders were bullish, while 35% showed bearish tendencies.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.413559"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.495866"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.13243,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.679118",
        "ticker_sentiment_score": "0.152347",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BCS",
        "relevance_score": "0.087824",
        "ticker_sentiment_score": "-0.119755",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Wall Street Analysts Look Bullish on Zoetis  ( ZTS ) : Should You Buy?",
    "url": "https://www.zacks.com/stock/news/2263218/wall-street-analysts-look-bullish-on-zoetis-zts-should-you-buy",
    "time_published": "20240426T133009",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "According to the average brokerage recommendation (ABR), one should invest in Zoetis (ZTS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default109.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.938238"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.503496"
      }
    ],
    "overall_sentiment_score": 0.291935,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.360752",
        "ticker_sentiment_score": "0.177656",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "ROSEN, A TOP RANKED LAW FIRM, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS",
    "url": "https://www.prnewswire.com/news-releases/rosen-a-top-ranked-law-firm-encourages-zoetis-inc-investors-to-inquire-about-securities-class-action-investigation--zts-302128225.html",
    "time_published": "20240427T023200",
    "authors": [
      "THE ROSEN LAW FIRM",
      "P. A."
    ],
    "summary": "ROSEN, A TOP RANKED LAW FIRM, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action ... PR ...",
    "banner_image": "https://mma.prnewswire.com/media/405060/Rosen_Law_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.614606"
      }
    ],
    "overall_sentiment_score": 0.189009,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.503018",
        "ticker_sentiment_score": "0.042059",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "META",
        "relevance_score": "0.090134",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zoetis Inc. - ZTS",
    "url": "https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-zoetis-inc---zts-302127971.html",
    "time_published": "20240428T130000",
    "authors": [
      "Pomerantz LLP"
    ],
    "summary": "NEW YORK, April 28, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zoetis Inc. ( \"Zoetis\" or the \"Company\" ) ( NYSE: ZTS ) . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.",
    "banner_image": "https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.066068,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.642555",
        "ticker_sentiment_score": "0.093129",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday - Tesla  ( NASDAQ:TSLA ) ",
    "url": "https://www.benzinga.com/news/24/04/38492833/tesla-deciphera-pharmaceuticals-heartland-financial-and-other-big-stocks-moving-higher-on-monday",
    "time_published": "20240429T144740",
    "authors": [
      "Avi Kapoor"
    ],
    "summary": "U.S. stocks were higher, with the Nasdaq Composite jumping over 50 points on Monday. Shares of Tesla, Inc. TSLA rose sharply during Monday's session on reports the company will partner with Baidu for mapping and navigation for Full Self-Driving in China. Tesla shares jumped 10.5% to $185.94 on ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/04/29/Tesla-logo_0.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.2"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.2"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.2"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.2"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.2"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      }
    ],
    "overall_sentiment_score": 0.228997,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MPLN",
        "relevance_score": "0.221481",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ROKU",
        "relevance_score": "0.221481",
        "ticker_sentiment_score": "0.20041",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PARA",
        "relevance_score": "0.148731",
        "ticker_sentiment_score": "-0.027195",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BIDU",
        "relevance_score": "0.074692",
        "ticker_sentiment_score": "0.007147",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PAHC",
        "relevance_score": "0.221481",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MESO",
        "relevance_score": "0.148731",
        "ticker_sentiment_score": "0.106806",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TSLA",
        "relevance_score": "0.221481",
        "ticker_sentiment_score": "0.1128",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.074692",
        "ticker_sentiment_score": "0.018481",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.074692",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FNLC",
        "relevance_score": "0.074692",
        "ticker_sentiment_score": "0.11105",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TNDM",
        "relevance_score": "0.148731",
        "ticker_sentiment_score": "0.023996",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HTLF",
        "relevance_score": "0.148731",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DCPH",
        "relevance_score": "0.148731",
        "ticker_sentiment_score": "0.218908",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "EAF",
        "relevance_score": "0.148731",
        "ticker_sentiment_score": "0.428867",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "FRBK",
        "relevance_score": "0.074692",
        "ticker_sentiment_score": "0.11105",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PACB",
        "relevance_score": "0.148731",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DNA",
        "relevance_score": "0.148731",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FULT",
        "relevance_score": "0.221481",
        "ticker_sentiment_score": "0.183831",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ALB",
        "relevance_score": "0.148731",
        "ticker_sentiment_score": "0.133889",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ALTM",
        "relevance_score": "0.148731",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EXAI",
        "relevance_score": "0.148731",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TELLL",
        "relevance_score": "0.074692",
        "ticker_sentiment_score": "0.347222",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "UMBF",
        "relevance_score": "0.074692",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SLNO",
        "relevance_score": "0.148731",
        "ticker_sentiment_score": "0.177961",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "IBRX",
        "relevance_score": "0.221481",
        "ticker_sentiment_score": "0.358618",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "OPHLF",
        "relevance_score": "0.074692",
        "ticker_sentiment_score": "0.174934",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PRME",
        "relevance_score": "0.148731",
        "ticker_sentiment_score": "0.198629",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "BioCryst Pharmaceuticals  ( BCRX )  Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release",
    "url": "https://www.zacks.com/stock/news/2264204/biocryst-pharmaceuticals-bcrx-expected-to-beat-earnings-estimates-what-to-know-ahead-of-q1-release",
    "time_published": "20240429T140031",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "BioCryst (BCRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default215.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.316726"
      }
    ],
    "overall_sentiment_score": 0.142673,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "BCRX",
        "relevance_score": "0.088964",
        "ticker_sentiment_score": "0.11485",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.176825",
        "ticker_sentiment_score": "-0.002872",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Unveiling Zoetis  ( ZTS )  Q1 Outlook: Wall Street Estimates for Key Metrics",
    "url": "https://www.zacks.com/stock/news/2263927/unveiling-zoetis-zts-q1-outlook-wall-street-estimates-for-key-metrics",
    "time_published": "20240429T131605",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Besides Wall Street's top -and-bottom-line estimates for Zoetis (ZTS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default362.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.972476"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.11304,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.355588",
        "ticker_sentiment_score": "0.20635",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Should You Invest in the VanEck Agribusiness ETF  ( MOO ) ?",
    "url": "https://www.zacks.com/stock/news/2263749/should-you-invest-in-the-vaneck-agribusiness-etf-moo",
    "time_published": "20240429T102004",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Sector ETF report for MOO ...",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default335.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.999996"
      }
    ],
    "overall_sentiment_score": 0.149731,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.142565",
        "ticker_sentiment_score": "0.073749",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DE",
        "relevance_score": "0.142565",
        "ticker_sentiment_score": "0.073749",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CTVA",
        "relevance_score": "0.142565",
        "ticker_sentiment_score": "0.073749",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ",
    "url": "https://www.benzinga.com/news/earnings/24/04/38481553/will-earnings-cheer-continue-to-buoy-markets-apple-amazon-pfizer-coinbase-lead-flurry-of-q1-reports",
    "time_published": "20240429T055121",
    "authors": [
      "Shanthi Rexaline"
    ],
    "summary": "Corporate earnings came to the market's rescue in the past week, helping to overcome rate fears. As we look ahead to the unfolding week, it remains to be seen whether the tech earnings deluge can keep the rally's momentum going.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/04/29/Market.png?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.142857"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.142857"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.142857"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.142857"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.142857"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.961735"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.142857"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.999917"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.142857"
      }
    ],
    "overall_sentiment_score": 0.260382,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DD",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MSTR",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ALL",
        "relevance_score": "0.03468",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AAPL",
        "relevance_score": "0.239137",
        "ticker_sentiment_score": "0.076466",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LSCC",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LOGI",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "KHC",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NOVA",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "UPWK",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AMGN",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "COIN",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PFE",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TSLA",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.271882",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MA",
        "relevance_score": "0.03468",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NTGR",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "KLIC",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "QGEN",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FIVN",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "YUMC",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ED",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DKNG",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "META",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.120474",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EG",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WING",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ILMN",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MT",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BLCO",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "OMI",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SANM",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RGA",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "KIM",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HSY",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "YUM",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FSLR",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EBAY",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SOFI",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MRNA",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "QRVO",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MET",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PXD",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CVS",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PARA",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EXPE",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MRO",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IVZ",
        "relevance_score": "0.03468",
        "ticker_sentiment_score": "0.111638",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FFIV",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FLR",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PENN",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NCLH",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "XPO",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "W",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "X",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CYBR",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "Z",
        "relevance_score": "0.03468",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BKNG",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GSK",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ON",
        "relevance_score": "0.03468",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "COP",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MNST",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NXPI",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LYV",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CBOE",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ICE",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RMBS",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GRMN",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "OPEN",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BZH",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MGM",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AXL",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ETSY",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "REG",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ALB",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WOLF",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NET",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DVN",
        "relevance_score": "0.069294",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AMZN",
        "relevance_score": "0.138066",
        "ticker_sentiment_score": "0.214972",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Zoetis  ( ZTS )  Stock Declines Amid Concerns Over Arthritis Drugs Impacting Pets - Hagens Berman - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/pressreleases/24/04/g38531595/zoetis-zts-stock-declines-amid-concerns-over-arthritis-drugs-impacting-pets-hagens-berman",
    "time_published": "20240430T185154",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "SAN FRANCISCO, April 30, 2024 ( GLOBE NEWSWIRE ) -- Hagens Berman, a prominent national trial law firm, is urging investors who suffered substantial losses in Zoetis Inc. ZTS to promptly report their losses here.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": -0.002457,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.736708",
        "ticker_sentiment_score": "-0.015878",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "This Is What Whales Are Betting On Zoetis - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/insights/options/24/04/38529280/this-is-what-whales-are-betting-on-zoetis",
    "time_published": "20240430T171603",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Financial giants have made a conspicuous bearish move on Zoetis. Our analysis of options history for Zoetis ZTS revealed 10 unusual trades. Delving into the details, we found 30% of traders were bullish, while 70% showed bearish tendencies.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.495866"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.127919,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.702807",
        "ticker_sentiment_score": "0.022894",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BCS",
        "relevance_score": "0.092213",
        "ticker_sentiment_score": "-0.023606",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "ROSEN, SKILLED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/pressreleases/24/04/g38528126/rosen-skilled-investor-counsel-encourages-zoetis-inc-investors-to-inquire-about-securities-class-a",
    "time_published": "20240430T163945",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "NEW YORK, April 30, 2024 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Zoetis Inc. ZTS resulting from allegations that Zoetis may have issued materially misleading business ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.744043"
      }
    ],
    "overall_sentiment_score": 0.177147,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.428632",
        "ticker_sentiment_score": "0.037973",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "META",
        "relevance_score": "0.075161",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "1 Magnificent Dividend Growth Stock That's Down 40% and Trading at a Once-in-a-Decade Valuation",
    "url": "https://www.fool.com/investing/2024/04/30/1-unstoppable-dividend-growth-stock-to-buy-right/",
    "time_published": "20240430T110000",
    "authors": [
      "Josh Kohn-Lindquist"
    ],
    "summary": "The temporary problems facing Zoetis could create an incredible opportunity for investors thinking decades ahead.",
    "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F773731%2Fgetty-happy-interested-cat-and-dog.jpg&op=resize&w=700",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.961735"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.146802,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.871815",
        "ticker_sentiment_score": "0.241117",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PFE",
        "relevance_score": "0.048523",
        "ticker_sentiment_score": "-0.007952",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Phibro  ( PAHC )  Moves 31.8% Higher: Will This Strength Last?",
    "url": "https://www.zacks.com/stock/news/2264598/phibro-pahc-moves-318-higher-will-this-strength-last",
    "time_published": "20240430T080600",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Phibro (PAHC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default44.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.316726"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.972476"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.235159,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.106541",
        "ticker_sentiment_score": "0.216602",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PAHC",
        "relevance_score": "0.312158",
        "ticker_sentiment_score": "0.285842",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "QIPT",
        "relevance_score": "0.496915",
        "ticker_sentiment_score": "-0.077267",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Why Zoetis Stock Popped by Almost 6% on Thursday",
    "url": "https://www.fool.com/investing/2024/05/02/why-zoetis-stock-popped-by-almost-6-on-thursday/",
    "time_published": "20240502T205600",
    "authors": [
      "Eric Volkman"
    ],
    "summary": "An estimates-beating quarter and raised guidance made the company a pet stock for many investors.",
    "banner_image": "https://g.foolcdn.com/editorial/images/775594/kitten-with-its-tongue-out-and-eyes-closed.jpg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.990893"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.344666,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.628066",
        "ticker_sentiment_score": "0.543005",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Zoetis  ( ZTS )  Q1 Earnings and Revenues Surpass Estimates",
    "url": "https://www.zacks.com/stock/news/2267318/zoetis-zts-q1-earnings-and-revenues-surpass-estimates",
    "time_published": "20240502T163200",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Zoetis (ZTS) reports better-than-expected first-quarter results, wherein both earnings and revenues beat estimates. Shares rise.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/a7/2964.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999985"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.128589,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.537213",
        "ticker_sentiment_score": "0.36145",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "PAHC",
        "relevance_score": "0.041828",
        "ticker_sentiment_score": "0.149054",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LGND",
        "relevance_score": "0.166169",
        "ticker_sentiment_score": "0.121992",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BPMC",
        "relevance_score": "0.166169",
        "ticker_sentiment_score": "0.056762",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ANVS",
        "relevance_score": "0.166169",
        "ticker_sentiment_score": "0.016919",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Why Animal Health-Focused Zoetis Shares Are Trading Higher Today - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/news/earnings/24/05/38585569/why-animal-health-focused-zoetis-shares-are-trading-higher-today",
    "time_published": "20240502T140834",
    "authors": [
      "Lekha Gupta"
    ],
    "summary": "Zoetis Inc ZTS shares are trading higher after the company reported first-quarter FY24 revenue of $2.19 billion, up 10% Y/Y on reported and 12% Y/Y on an operational basis, beating the consensus of $2.132 billion. Revenue in the U.S. segment was $1.2 billion, up 16% Y/Y.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/02/Cat.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.94762"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.77141"
      }
    ],
    "overall_sentiment_score": 0.26442,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.61135",
        "ticker_sentiment_score": "0.243018",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine",
    "url": "https://www.barrons.com/amp/articles/zoetis-earnings-stock-medicine-safety-6b7efe84",
    "time_published": "20240502T130600",
    "authors": [
      "Josh Nathan-Kazis"
    ],
    "summary": "Zoetis reported financial results for the first quarter that were slightly better than Wall Street expected, as worries about its new pain medicines for dogs and cats continue to weigh on the stock.",
    "banner_image": "https://images.barrons.com/im-666952/social",
    "source": "Barrons",
    "category_within_source": "n/a",
    "source_domain": "www.barrons.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.684621"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.967321"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.045909,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "BAC",
        "relevance_score": "0.056143",
        "ticker_sentiment_score": "0.051051",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ELAN",
        "relevance_score": "0.056143",
        "ticker_sentiment_score": "0.049011",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.561452",
        "ticker_sentiment_score": "-0.013888",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Zoetis  ( ZTS )  Beats Q1 Earnings and Revenue Estimates",
    "url": "https://www.zacks.com/stock/news/2266723/zoetis-zts-beats-q1-earnings-and-revenue-estimates",
    "time_published": "20240502T121008",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Zoetis (ZTS) delivered earnings and revenue surprises of 2.99% and 2.36%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default89.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999992"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.137305,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.405651",
        "ticker_sentiment_score": "0.112593",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FGEN",
        "relevance_score": "0.140896",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Pet Drugmaker Zoetis Rises On Earnings Beat",
    "url": "https://www.investors.com/news/technology/zoetis-stock-zoetis-earnings-q1-2024/",
    "time_published": "20240502T112700",
    "authors": [
      "Investor's Business Daily",
      "ALLISON GATLIN"
    ],
    "summary": "Zoetis Stock: Zoetis Earnings Top. Pet Drugmaker Rises Investor's Business Daily ...",
    "banner_image": "https://www.investors.com/wp-content/uploads/2019/09/stock-Zoetis-02-shutter.jpg",
    "source": "Investors Business Daily",
    "category_within_source": "n/a",
    "source_domain": "www.investors.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.875462"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.989041"
      }
    ],
    "overall_sentiment_score": 0.173964,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.899125",
        "ticker_sentiment_score": "0.283964",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Nasdaq, S&P 500 Futures Rise Ahead Of Apple Earnings: What's Going On With Stock Market? - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ",
    "url": "https://www.benzinga.com/news/earnings/24/05/38576979/nasdaq-s-p-500-futures-rise-ahead-of-apple-earnings-why-this-analyst-thinks-no-cut-scenario-may-not",
    "time_published": "20240502T105251",
    "authors": [
      "Shanthi Rexaline"
    ],
    "summary": "U.S. stocks look to push ahead on a positive path, now that the Federal Reserve's rate decision is in the rearview mirror. Major index futures point to a positive open on Thursday.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/02/Wall-Street.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.142857"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.142857"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.142857"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.142857"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.682689"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.142857"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.316726"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.142857"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.682689"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.142857"
      }
    ],
    "overall_sentiment_score": 0.081907,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "AAPL",
        "relevance_score": "0.133655",
        "ticker_sentiment_score": "-0.055256",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.097849",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EXPE",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NOVA",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.020026",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "UPWK",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.020026",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AMGN",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DASH",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.020026",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "COIN",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PENN",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NTGR",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.020026",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "W",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "KLIC",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.020026",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "X",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CYBR",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "Z",
        "relevance_score": "0.033562",
        "ticker_sentiment_score": "0.018657",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FIVN",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BKNG",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ED",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DKNG",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "COP",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ILMN",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MNST",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LYV",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ICE",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RGA",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "KIM",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "OPEN",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FSLR",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.020026",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MGM",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.020026",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EBAY",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.020026",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ETSY",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.020026",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "REG",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WOLF",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.020026",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MRNA",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NET",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "QRVO",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.020026",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PXD",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AMZN",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.097849",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CRYPTO:BTC",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.029538",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Zoetis Exceeds Q1 Earnings Expectations",
    "url": "https://www.fool.com/investing/2024/05/03/zoetis-exceeds-q1-earnings-expectations/",
    "time_published": "20240503T191256",
    "authors": [
      "JesterAI"
    ],
    "summary": "The animal healthcare company delivered a robust performance, aided by some easy year-over-year comparisons.",
    "banner_image": "https://g.foolcdn.com/editorial/images/775570/cat-being-seen-by-vet-with-stethoscope.jpg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999346"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.517788,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.546745",
        "ticker_sentiment_score": "0.575551",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Zoetis  ( ZTS )  Q1 2024 Earnings Call Transcript",
    "url": "https://www.fool.com/earnings/call-transcripts/2024/05/03/zoetis-zts-q1-2024-earnings-call-transcript/",
    "time_published": "20240503T130023",
    "authors": [
      "Motley Fool Transcribing"
    ],
    "summary": "ZTS earnings call for the period ending March 31, 2024.",
    "banner_image": "https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "IPO",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "1.0"
      },
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.288065,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.049314",
        "ticker_sentiment_score": "0.173379",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PAHC",
        "relevance_score": "0.007592",
        "ticker_sentiment_score": "0.159814",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BCS",
        "relevance_score": "0.007592",
        "ticker_sentiment_score": "0.139956",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BAC",
        "relevance_score": "0.003796",
        "ticker_sentiment_score": "0.006202",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GS",
        "relevance_score": "0.003796",
        "ticker_sentiment_score": "0.304418",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MS",
        "relevance_score": "0.003796",
        "ticker_sentiment_score": "0.128822",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "ROSEN, A TOP RANKED LAW FIRM, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/pressreleases/24/05/g38629891/rosen-a-top-ranked-law-firm-encourages-zoetis-inc-investors-to-inquire-about-securities-class-acti",
    "time_published": "20240504T134400",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "NEW YORK, May 04, 2024 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Zoetis Inc. ZTS resulting from allegations that Zoetis may have issued materially misleading business ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.744043"
      }
    ],
    "overall_sentiment_score": 0.177153,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.428632",
        "ticker_sentiment_score": "0.040896",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "META",
        "relevance_score": "0.075161",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Is Trending Stock Zoetis Inc.  ( ZTS )  a Buy Now?",
    "url": "https://www.zacks.com/stock/news/2268520/is-trending-stock-zoetis-inc-zts-a-buy-now",
    "time_published": "20240506T130010",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Zacks.com users have recently been watching Zoetis (ZTS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default208.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999999"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.5855"
      }
    ],
    "overall_sentiment_score": 0.243559,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.523995",
        "ticker_sentiment_score": "0.168722",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Brains Bioceutical Announces the Addition of Industry Veteran John Boshart to its Animal Health Division",
    "url": "https://www.benzinga.com/pressreleases/24/05/g38636256/brains-bioceutical-announces-the-addition-of-industry-veteran-john-boshart-to-its-animal-health-di",
    "time_published": "20240506T100000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "VANCOUVER, British Columbia, May 06, 2024 ( GLOBE NEWSWIRE ) -- Today marks a pivotal development for Brains Bioceutical Corp ( \"Brains Bio\" ) , as it significantly strengthens its Veterinary Health Division.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.5"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.474414,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "APG",
        "relevance_score": "0.18602",
        "ticker_sentiment_score": "0.238083",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.046907",
        "ticker_sentiment_score": "0.192507",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PFE",
        "relevance_score": "0.046907",
        "ticker_sentiment_score": "0.192507",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TSOI",
        "relevance_score": "0.046907",
        "ticker_sentiment_score": "0.040922",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Elanco Animal Health  ( ELAN )  Q1 2024 Earnings Call Transcript",
    "url": "https://www.fool.com/earnings/call-transcripts/2024/05/08/elanco-animal-health-elan-q1-2024-earnings-call-tr/",
    "time_published": "20240508T180017",
    "authors": [
      "Motley Fool Transcribing"
    ],
    "summary": "ELAN earnings call for the period ending March 31, 2024.",
    "banner_image": "https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "1.0"
      },
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.329791,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "EVR",
        "relevance_score": "0.004407",
        "ticker_sentiment_score": "0.21086",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BCS",
        "relevance_score": "0.008813",
        "ticker_sentiment_score": "0.208567",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BAC",
        "relevance_score": "0.004407",
        "ticker_sentiment_score": "0.202467",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ELAN",
        "relevance_score": "0.004407",
        "ticker_sentiment_score": "0.078672",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MS",
        "relevance_score": "0.004407",
        "ticker_sentiment_score": "0.202467",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.008813",
        "ticker_sentiment_score": "0.052163",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GS",
        "relevance_score": "0.004407",
        "ticker_sentiment_score": "0.331439",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "FPH",
        "relevance_score": "0.004407",
        "ticker_sentiment_score": "0.222133",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "FOREX:USD",
        "relevance_score": "0.004407",
        "ticker_sentiment_score": "0.13607",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Zoetis  ( ZTS )  Stock Declines Amid Concerns Over Arthritis Drugs Impacting Pets - Hagens Berman - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/pressreleases/24/05/g38703128/zoetis-zts-stock-declines-amid-concerns-over-arthritis-drugs-impacting-pets-hagens-berman",
    "time_published": "20240508T142337",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "SAN FRANCISCO, May 08, 2024 ( GLOBE NEWSWIRE ) -- Hagens Berman, a prominent national trial law firm, is urging investors who suffered substantial losses in Zoetis Inc. ZTS to promptly report their losses here.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": -0.002457,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.736708",
        "ticker_sentiment_score": "-0.015878",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Is Buddy's Drugmaker Making A Comeback? Shares Vault 50-Day Line.",
    "url": "https://www.investors.com/news/technology/elanco-stock-elanco-animal-health-earnings-q1-2024/",
    "time_published": "20240508T142000",
    "authors": [
      "Investor's Business Daily",
      "ALLISON GATLIN"
    ],
    "summary": "Elanco Stock Flashes A Bullish Sign After Beating First Quarter Calls Investor's Business Daily ...",
    "banner_image": "https://www.investors.com/wp-content/uploads/2021/06/Stock-Elanco-shutt.jpg",
    "source": "Investors Business Daily",
    "category_within_source": "n/a",
    "source_domain": "www.investors.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.451494"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.989041"
      }
    ],
    "overall_sentiment_score": 0.149767,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ELAN",
        "relevance_score": "0.16171",
        "ticker_sentiment_score": "-0.006946",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.16171",
        "ticker_sentiment_score": "0.034027",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Bragar Eagel & Squire, P.C. Is Investigating Zoetis, and Morgan Stanley and Encourages Investors to Contact the Firm - Morgan Stanley  ( NYSE:MS ) , Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/pressreleases/24/05/g38688754/bragar-eagel-squire-p-c-is-investigating-zoetis-and-morgan-stanley-and-encourages-investors-to-con",
    "time_published": "20240508T010000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "NEW YORK, May 07, 2024 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Zoetis Inc.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.684621"
      }
    ],
    "overall_sentiment_score": 0.002435,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.654016",
        "ticker_sentiment_score": "-0.245557",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "MS",
        "relevance_score": "0.567746",
        "ticker_sentiment_score": "-0.003473",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Phibro  ( PAHC )  Q3 Earnings and Revenues Beat, Gross Margin Down",
    "url": "https://www.zacks.com/stock/news/2271539/phibro-pahc-q3-earnings-and-revenues-beat-gross-margin-down",
    "time_published": "20240509T141800",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Phibro's (PAHC) impressive fiscal 2024 third-quarter performance continues to be driven by the Animal Health segment.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/c0/53200.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999998"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.538269"
      }
    ],
    "overall_sentiment_score": 0.05661,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "INSP",
        "relevance_score": "0.1871",
        "ticker_sentiment_score": "0.043592",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.047185",
        "ticker_sentiment_score": "0.123451",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EHC",
        "relevance_score": "0.1871",
        "ticker_sentiment_score": "0.104351",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PAHC",
        "relevance_score": "0.1871",
        "ticker_sentiment_score": "0.067513",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HIMS",
        "relevance_score": "0.1871",
        "ticker_sentiment_score": "0.102876",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zoetis Inc. - ZTS - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/pressreleases/24/05/g38779102/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-zoetis-inc-zts",
    "time_published": "20240512T151500",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "NEW YORK, May 12, 2024 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Zoetis Inc. ( \"Zoetis\" or the \"Company\" ) ZTS. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.075674,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.565345",
        "ticker_sentiment_score": "0.017464",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Here's How Much $100 Invested In Zoetis 10 Years Ago Would Be Worth Today - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/insights/news/24/05/38950526/heres-how-much-100-invested-in-zoetis-10-years-ago-would-be-worth-today",
    "time_published": "20240521T200026",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Zoetis ZTS has outperformed the market over the past 10 years by 8.14% on an annualized basis producing an average annual return of 18.88%. Currently, Zoetis has a market capitalization of $79.39 billion.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_1.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.238974,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.95919",
        "ticker_sentiment_score": "0.384695",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zoetis Inc. - ZTS - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/pressreleases/24/05/g38948289/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-zoetis-inc-zts",
    "time_published": "20240521T174628",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "NEW YORK, May 21, 2024 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Zoetis Inc. ( \"Zoetis\" or the \"Company\" ) ZTS. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.075674,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.565345",
        "ticker_sentiment_score": "0.017464",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zoetis Inc. - ZTS - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/pressreleases/24/05/g39047374/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-zoetis-inc-zts",
    "time_published": "20240528T203940",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "NEW YORK, May 28, 2024 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Zoetis Inc. ( \"Zoetis\" or the \"Company\" ) ZTS. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.075674,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.565345",
        "ticker_sentiment_score": "0.017464",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Zoetis  ( ZTS )  Stock Declines Amid Concerns Over Arthritis Drugs Impacting Pets - Hagens Berman - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/pressreleases/24/05/g39069448/zoetis-zts-stock-declines-amid-concerns-over-arthritis-drugs-impacting-pets-hagens-berman",
    "time_published": "20240529T165324",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "SAN FRANCISCO, May 29, 2024 ( GLOBE NEWSWIRE ) -- Hagens Berman is urging investors who suffered substantial losses in Zoetis Inc. ZTS to promptly report their losses here. Additionally, individuals with relevant knowledge who may assist in the investigation are encouraged to contact the firm's ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": -0.06334,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.7868",
        "ticker_sentiment_score": "-0.253101",
        "ticker_sentiment_label": "Somewhat-Bearish"
      }
    ]
  },
  {
    "title": "Here's How Much $100 Invested In Zoetis 10 Years Ago Would Be Worth Today - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/insights/news/24/05/39093960/heres-how-much-100-invested-in-zoetis-10-years-ago-would-be-worth-today",
    "time_published": "20240530T173022",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Zoetis ZTS has outperformed the market over the past 10 years by 7.9% on an annualized basis producing an average annual return of 18.41%. Currently, Zoetis has a market capitalization of $79.24 billion.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_1.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.238974,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.95919",
        "ticker_sentiment_score": "0.384695",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Beat the Dow Jones With This Cash-Gushing Dividend Stock",
    "url": "https://www.fool.com/investing/2024/05/30/beat-the-dow-jones-with-this-cash-gushing-dividend/",
    "time_published": "20240530T121500",
    "authors": [
      "Josh Kohn-Lindquist"
    ],
    "summary": "With one decade of doubling the Dow Jones' total return under its belt, Zoetis looks ready to deliver another 10 years of outperformance.",
    "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F778424%2Fanimals-46.jpg&op=resize&w=700",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "IPO",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.451494"
      }
    ],
    "overall_sentiment_score": 0.165468,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.61177",
        "ticker_sentiment_score": "0.22839",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PFE",
        "relevance_score": "0.052918",
        "ticker_sentiment_score": "0.047748",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AWON",
        "relevance_score": "0.052918",
        "ticker_sentiment_score": "0.163665",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Peering Into Zoetis's Recent Short Interest - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/insights/short-sellers/24/06/39146809/peering-into-zoetiss-recent-short-interest",
    "time_published": "20240603T203025",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Zoetis's ZTS short percent of float has risen 16.81% since its last report. The company recently reported that it has 6.03 million shares sold short, which is 1.32% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.94 days to cover their ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.289997,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.212115",
        "ticker_sentiment_score": "0.151778",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zoetis Inc. - ZTS - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/pressreleases/24/06/g39196238/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-zoetis-inc-zts",
    "time_published": "20240605T220830",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "NEW YORK, June 05, 2024 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Zoetis Inc. ( \"Zoetis\" or the \"Company\" ) ZTS. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.075674,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.565345",
        "ticker_sentiment_score": "0.017464",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "USNA vs. ZTS: Which Stock Is the Better Value Option?",
    "url": "https://www.zacks.com/stock/news/2284152/usna-vs-zts-which-stock-is-the-better-value-option",
    "time_published": "20240605T154015",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Investors interested in stocks from the Medical - Drugs sector have probably already heard of USANA Health Sciences ( USNA Quick QuoteUSNA - ) and Zoetis ( ZTS Quick QuoteZTS - ) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer ...",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default279.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.769861"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.532748,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "HESG",
        "relevance_score": "0.199859",
        "ticker_sentiment_score": "0.361231",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.624423",
        "ticker_sentiment_score": "0.610795",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "USNA",
        "relevance_score": "0.745397",
        "ticker_sentiment_score": "0.64754",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Why Is Esperion Therapeutics  ( ESPR )  Up 14.2% Since Last Earnings Report?",
    "url": "https://www.zacks.com/stock/news/2284858/why-is-esperion-therapeutics-espr-up-142-since-last-earnings-report",
    "time_published": "20240606T153109",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Esperion Therapeutics (ESPR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default29.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "IPO",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.459462"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.96136"
      }
    ],
    "overall_sentiment_score": 0.128615,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ESPR",
        "relevance_score": "0.256719",
        "ticker_sentiment_score": "0.237398",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.206685",
        "ticker_sentiment_score": "0.058539",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SKXJF",
        "relevance_score": "0.052226",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DSKYF",
        "relevance_score": "0.052226",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zoetis Inc. - ZTS",
    "url": "https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-zoetis-inc---zts-302167233.html",
    "time_published": "20240607T190300",
    "authors": [
      "Pomerantz LLP"
    ],
    "summary": "NEW YORK, June 7, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zoetis Inc. ( \"Zoetis\" or the \"Company\" ) ( NYSE: ZTS ) . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.",
    "banner_image": "https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.066068,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.642555",
        "ticker_sentiment_score": "0.093129",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Why Is Catalent  ( CTLT )  Up 0.4% Since Last Earnings Report?",
    "url": "https://www.zacks.com/stock/news/2285463/why-is-catalent-ctlt-up-04-since-last-earnings-report",
    "time_published": "20240607T153054",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Catalent (CTLT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default346.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.99915"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.929393"
      }
    ],
    "overall_sentiment_score": 0.071397,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.24289",
        "ticker_sentiment_score": "0.06662",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CTLT",
        "relevance_score": "0.513494",
        "ticker_sentiment_score": "0.169279",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Theravance Bio  ( TBPH )  Down 6.1% Since Last Earnings Report: Can It Rebound?",
    "url": "https://www.zacks.com/stock/news/2287393/theravance-bio-tbph-down-61-since-last-earnings-report-can-it-rebound",
    "time_published": "20240612T153004",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Theravance Bio (TBPH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default84.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.938238"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.042928,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.277433",
        "ticker_sentiment_score": "0.072258",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TBPH",
        "relevance_score": "0.070725",
        "ticker_sentiment_score": "-0.004062",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "VTRS",
        "relevance_score": "0.140896",
        "ticker_sentiment_score": "0.106437",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Two dozen companies working to find bird flu vaccine for cows: US agri secy",
    "url": "https://www.business-standard.com/world-news/two-dozen-companies-working-to-find-bird-flu-vaccine-for-cows-us-agri-secy-124061300275_1.html",
    "time_published": "20240613T061635",
    "authors": [
      "Reuters"
    ],
    "summary": "A vaccine could curb the risk of bird flu spreading to new species. ( Photo: Bloomberg ) Twenty-four companies are working to develop an avian flu vaccine for cattle, as the virus spreads among US dairy herds, Agriculture Secretary Tom Vilsack told Reuters on Wednesday.",
    "banner_image": "https://bsmedia.business-standard.com/_media/bs/img/article/2024-06/11/full/1718071837-968.jpg?im=FitAndFill=(826,465)",
    "source": "Business Standard",
    "category_within_source": "GoogleRSS",
    "source_domain": "www.business-standard.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": -0.123663,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.092569",
        "ticker_sentiment_score": "0.055261",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "SKY'S THE LIMIT AS NORTH SHORE ANIMAL LEAGUE AMERICA'S \"CELEBRATION OF RESCUE\" STAR-STUDDED EVENT HONORS 80-YEAR ANNIVERSARY OF LIFE-SAVING WORK",
    "url": "https://www.benzinga.com/pressreleases/24/06/n39345325/skys-the-limit-as-north-shore-animal-league-americas-celebration-of-rescue-star-studded-event-hono",
    "time_published": "20240615T110000",
    "authors": [
      "PRNewswire"
    ],
    "summary": "Attendees Included Event Chairperson Beth Stern, Howard Stern, Event Host Maria Milito, Event Entertainer Taylor Dayne, Honorees Rachael Ray & John Cusimano, Kathryn Erbe, Robyn Schall, Dan Mannarino, and Others.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.449611,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.04303",
        "ticker_sentiment_score": "0.215224",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ZETA",
        "relevance_score": "0.04303",
        "ticker_sentiment_score": "0.215224",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MS",
        "relevance_score": "0.04303",
        "ticker_sentiment_score": "0.215224",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "SKY'S THE LIMIT AS NORTH SHORE ANIMAL LEAGUE AMERICA'S \"CELEBRATION OF RESCUE\" STAR-STUDDED ... - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/skys-the-limit-as-north-shore-animal-league-americas-celebration-of-rescue-star-studded-event-honors-80-year-anniversary-of-life-saving-work-302173533.html",
    "time_published": "20240615T110000",
    "authors": [],
    "summary": "SKY'S THE LIMIT AS NORTH SHORE ANIMAL LEAGUE AMERICA'S \"CELEBRATION OF RESCUE\" STAR-STUDDED ... PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.466423,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.041682",
        "ticker_sentiment_score": "0.214665",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ZETA",
        "relevance_score": "0.041682",
        "ticker_sentiment_score": "0.214665",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MS",
        "relevance_score": "0.041682",
        "ticker_sentiment_score": "0.214665",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Here's How Much You Would Have Made Owning Zoetis Stock In The Last 10 Years - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/insights/news/24/06/39388722/heres-how-much-you-would-have-made-owning-zoetis-stock-in-the-last-10-years",
    "time_published": "20240618T200018",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Zoetis ZTS has outperformed the market over the past 10 years by 7.14% on an annualized basis producing an average annual return of 18.04%. Currently, Zoetis has a market capitalization of $77.57 billion.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_4.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.238974,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.95919",
        "ticker_sentiment_score": "0.384695",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "UNITED KENNEL CLUB ANNOUNCES PARTNERSHIP WITH LIBRELA\u2122",
    "url": "https://www.benzinga.com/pressreleases/24/06/n39383077/united-kennel-club-announces-partnership-with-librela",
    "time_published": "20240618T151400",
    "authors": [
      "PRNewswire"
    ],
    "summary": "New Partnership Kicks Off in Second Quarter of 2024! KALAMAZOO, Mich., June 18, 2024 /PRNewswire/ -- United Kennel Club ( UKC\u2122 ) , today announced a 2024 partnership with Librela\u2122 ( bedinvetmab injection ) .",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.175823,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.267315",
        "ticker_sentiment_score": "0.101353",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "BMY: 3 Pharmaceutical Stocks With Blockbuster Potential",
    "url": "https://stocknews.com/news/bmy-zts-vtrs-3-pharmaceutical-stocks-with-blockbuster-potential/",
    "time_published": "20240621T170737",
    "authors": [
      "StockNews.com Staff"
    ],
    "summary": "The pharmaceutical industry is well-positioned for significant expansion, driven by robust demand amid the growing prevalence of chronic diseases and an aging population, continued innovations and discoveries in drug discovery and development, and technological advances such as AI, big data ...",
    "banner_image": "https://stocknews.com/wp-content/uploads/2024/04/Rajkumari-Saxena_Image-1.jpeg",
    "source": "Stocknews.com",
    "category_within_source": "n/a",
    "source_domain": "stocknews.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999897"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.99999"
      }
    ],
    "overall_sentiment_score": 0.216373,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.356373",
        "ticker_sentiment_score": "0.218679",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BMY",
        "relevance_score": "0.278063",
        "ticker_sentiment_score": "0.182488",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "VTRS",
        "relevance_score": "0.304542",
        "ticker_sentiment_score": "0.165877",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "USNA or ZTS: Which Is the Better Value Stock Right Now?",
    "url": "https://www.zacks.com/stock/news/2291650/usna-or-zts-which-is-the-better-value-stock-right-now",
    "time_published": "20240621T154010",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "USNA vs. ZTS: Which Stock Is the Better Value Option?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default143.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.795202"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.516739,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "HESG",
        "relevance_score": "0.197413",
        "ticker_sentiment_score": "0.355294",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.618426",
        "ticker_sentiment_score": "0.59946",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "USNA",
        "relevance_score": "0.739411",
        "ticker_sentiment_score": "0.636814",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Peering Into Zoetis's Recent Short Interest - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/insights/short-sellers/24/06/39462739/peering-into-zoetiss-recent-short-interest",
    "time_published": "20240624T171519",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Zoetis's ZTS short percent of float has fallen 3.79% since its last report. The company recently reported that it has 5.80 million shares sold short, which is 1.27% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.52 days to cover their ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.264538,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.212115",
        "ticker_sentiment_score": "0.081887",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "How To Make Traveling With Pets Less Stressful For Them  ( And Easier For You ) ",
    "url": "https://www.forbes.com/sites/forbes-personal-shopper/article/traveling-with-pets/",
    "time_published": "20240625T184705",
    "authors": [
      "Emmy Favilla"
    ],
    "summary": "Traveling With Pets: Tips For A Stress-Free Trip Forbes ...",
    "banner_image": "https://imageio.forbes.com/specials-images/imageserve/667ad0657f295d966b653095/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
    "source": "Forbes",
    "category_within_source": "n/a",
    "source_domain": "www.forbes.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.240427,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.019411",
        "ticker_sentiment_score": "0.099533",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JWCTF",
        "relevance_score": "0.038811",
        "ticker_sentiment_score": "0.041489",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WOOF",
        "relevance_score": "0.038811",
        "ticker_sentiment_score": "0.039112",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Here's How Much $100 Invested In Zoetis 10 Years Ago Would Be Worth Today - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/insights/news/24/07/39636839/heres-how-much-100-invested-in-zoetis-10-years-ago-would-be-worth-today",
    "time_published": "20240704T170026",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Zoetis ZTS has outperformed the market over the past 10 years by 7.56% on an annualized basis producing an average annual return of 18.39%. Currently, Zoetis has a market capitalization of $80.07 billion.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_4.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.238974,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.95919",
        "ticker_sentiment_score": "0.384695",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "USNA vs. ZTS: Which Stock Is the Better Value Option?",
    "url": "https://www.zacks.com/stock/news/2297836/usna-vs-zts-which-stock-is-the-better-value-option",
    "time_published": "20240708T160020",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Investors interested in Medical - Drugs stocks are likely familiar with USANA Health Sciences ( USNA Quick QuoteUSNA - ) and Zoetis ( ZTS Quick QuoteZTS - ) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default93.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.838487"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.491242,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "HESG",
        "relevance_score": "0.197413",
        "ticker_sentiment_score": "0.337839",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.618426",
        "ticker_sentiment_score": "0.520324",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "USNA",
        "relevance_score": "0.739411",
        "ticker_sentiment_score": "0.587639",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "How Is The Market Feeling About Zoetis? - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/insights/short-sellers/24/07/39822344/how-is-the-market-feeling-about-zoetis",
    "time_published": "20240717T173018",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Zoetis's ZTS short percent of float has fallen 9.27% since its last report. The company recently reported that it has 6.25 million shares sold short, which is 1.37% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.1 days to cover their ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.264538,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.212115",
        "ticker_sentiment_score": "0.081887",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Here's How Much You Would Have Made Owning Zoetis Stock In The Last 10 Years - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/insights/news/24/07/39865305/heres-how-much-you-would-have-made-owning-zoetis-stock-in-the-last-10-years",
    "time_published": "20240719T180019",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Zoetis ZTS has outperformed the market over the past 10 years by 7.71% on an annualized basis producing an average annual return of 18.4%. Currently, Zoetis has a market capitalization of $81.78 billion.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_3.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.238974,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.95919",
        "ticker_sentiment_score": "0.384695",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Zoetis  ( ZTS )  Stock Drops Despite Market Gains: Important Facts to Note",
    "url": "https://www.zacks.com/stock/news/2310413/zoetis-zts-stock-drops-despite-market-gains-important-facts-to-note",
    "time_published": "20240726T221518",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Zoetis (ZTS) reachead $179.84 at the closing of the latest trading day, reflecting a -0.51% change compared to its last close.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default80.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.972476"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.167961,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.590482",
        "ticker_sentiment_score": "0.312067",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Zoetis  ( ZTS )  Earnings Expected to Grow: Should You Buy?",
    "url": "https://www.zacks.com/stock/news/2312025/zoetis-zts-earnings-expected-to-grow-should-you-buy",
    "time_published": "20240730T140115",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Zoetis (ZTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default16.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.147106,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "BCRX",
        "relevance_score": "0.087985",
        "ticker_sentiment_score": "0.03911",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.259727",
        "ticker_sentiment_score": "0.151179",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Zoetis  ( ZTS )  to Report Q2 Earnings: What's in the Cards?",
    "url": "https://www.zacks.com/stock/news/2313238/zoetis-zts-to-report-q2-earnings-whats-in-the-cards",
    "time_published": "20240731T141400",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Zoetis' (ZTS) higher companion animal product sales are expected to have driven revenues in the second quarter of 2024 in both the United States and International segments.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/a7/2964.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999756"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.132536,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "APLS",
        "relevance_score": "0.181477",
        "ticker_sentiment_score": "-0.086177",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BMRN",
        "relevance_score": "0.181477",
        "ticker_sentiment_score": "0.041056",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.57806",
        "ticker_sentiment_score": "0.273832",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DNLI",
        "relevance_score": "0.181477",
        "ticker_sentiment_score": "0.118052",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Zoetis  ( ZTS )  Advances While Market Declines: Some Information for Investors",
    "url": "https://www.zacks.com/stock/news/2314769/zoetis-zts-advances-while-market-declines-some-information-for-investors",
    "time_published": "20240801T221507",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "In the most recent trading session, Zoetis (ZTS) closed at $182.42, indicating a +1.32% shift from the previous trading day.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default197.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.997874"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.184444,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.468029",
        "ticker_sentiment_score": "0.127501",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Will Xeris Biopharma  ( XERS )  Report Negative Earnings Next Week? What You Should Know",
    "url": "https://www.zacks.com/stock/news/2314263/will-xeris-biopharma-xers-report-negative-earnings-next-week-what-you-should-know",
    "time_published": "20240801T140130",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Xeris Biopharma (XERS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default359.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.316726"
      },
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.126426,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.174587",
        "ticker_sentiment_score": "0.021162",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "XERS",
        "relevance_score": "0.259267",
        "ticker_sentiment_score": "0.009992",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Unveiling Zoetis  ( ZTS )  Q2 Outlook: Wall Street Estimates for Key Metrics",
    "url": "https://www.zacks.com/stock/news/2314040/unveiling-zoetis-zts-q2-outlook-wall-street-estimates-for-key-metrics",
    "time_published": "20240801T131526",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Beyond analysts' top -and-bottom-line estimates for Zoetis (ZTS), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2024.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default6.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.972476"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.119699,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.360752",
        "ticker_sentiment_score": "0.208559",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "UTHR or ZTS: Which Is the Better Value Stock Right Now?",
    "url": "https://www.zacks.com/stock/news/2315433/uthr-or-zts-which-is-the-better-value-stock-right-now",
    "time_published": "20240802T154012",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "UTHR vs. ZTS: Which Stock Is the Better Value Option?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default110.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.614606"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.511001,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.632565",
        "ticker_sentiment_score": "0.604586",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "UTHR",
        "relevance_score": "0.69701",
        "ticker_sentiment_score": "0.625252",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Here are 4 things we're watching closely in the stock market this week",
    "url": "https://www.cnbc.com/2024/08/04/here-are-4-things-were-watching-closely-in-the-stock-market-this-week.html",
    "time_published": "20240804T135944",
    "authors": [],
    "summary": "Expect earnings reports, and CEO commentaries, to drive the market action.",
    "banner_image": null,
    "source": "CNBC",
    "category_within_source": "Top News",
    "source_domain": "www.cnbc.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.142857"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.142857"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.142857"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.142857"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.451494"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.142857"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.98396"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.142857"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.947132"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.142857"
      }
    ],
    "overall_sentiment_score": 0.007224,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "APP",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MPC",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.097835",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ROAD",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RIVN",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WYNN",
        "relevance_score": "0.082582",
        "ticker_sentiment_score": "0.004136",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AMGN",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GLW",
        "relevance_score": "0.027571",
        "ticker_sentiment_score": "0.090183",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MPW",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.094835",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "KVUE",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.097835",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "UPST",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CEG",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.097835",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ARRY",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.164881",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ILMN",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BRK-A",
        "relevance_score": "0.027571",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BROS",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BCO",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "-0.056855",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZI",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FTNT",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "VST",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.094835",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FSLY",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ERJ",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HUBS",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HOOD",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CELH",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.097835",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CVS",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "-0.056855",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HIMS",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BLDR",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.097835",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DDOG",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.094835",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AXON",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RKLB",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.164881",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "HIMX",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.094835",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "O",
        "relevance_score": "0.027571",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SG",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.164881",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BCRX",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.097835",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ACMR",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "-0.056855",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SN",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.094835",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CGC",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PLTR",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ACB",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "-0.056855",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RDDT",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "APPS",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "VMC",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.097835",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SEDG",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "OSCR",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "-0.056855",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "OGN",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.097835",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GXO",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.097835",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SRPT",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVO",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "-0.056855",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DNUT",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.094835",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABNB",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SPG",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NFE",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DT",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "-0.056855",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CRON",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.094835",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "OXY",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "VFC",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PZZA",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.094835",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AMD",
        "relevance_score": "0.027571",
        "ticker_sentiment_score": "0.054424",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FIVN",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.164881",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "YUMC",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CLSK",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.164881",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MNKD",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "-0.056855",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AMR",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EMR",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "-0.056855",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PLUG",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.094835",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ASPN",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TSN",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ET",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SNEJF",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "-0.056855",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "YUM",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.097835",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CAR",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WYNMF",
        "relevance_score": "0.027571",
        "ticker_sentiment_score": "0.004759",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CAT",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.097835",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AVGO",
        "relevance_score": "0.027571",
        "ticker_sentiment_score": "0.054424",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PARA",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.164881",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TTD",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.164881",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "LUMN",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AXSM",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BNTX",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SHOP",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "-0.056855",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TDC",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SOUN",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.164881",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "OC",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.097835",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NKLA",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LLY",
        "relevance_score": "0.082582",
        "ticker_sentiment_score": "0.090235",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DUK",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.097835",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVAX",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.094835",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "UBER",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.097835",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "KRYS",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PLNT",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.097835",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CSX",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FRPT",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LCID",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MGNI",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BAX",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.097835",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CPNG",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GCT",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GILD",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.164881",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DVN",
        "relevance_score": "0.055109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FOREX:GBP",
        "relevance_score": "0.027571",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Home Depot To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Monday - Home Depot  ( NYSE:HD ) ",
    "url": "https://www.benzinga.com/news/24/08/40161976/home-depot-to-rally-more-than-14-here-are-10-top-analyst-forecasts-for-monday",
    "time_published": "20240805T142058",
    "authors": [
      "Avi Kapoor"
    ],
    "summary": "Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Stifel boosted the price target for Zoetis Inc. ZTS from $180 to $200.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/08/05/Home-Depot-Mike-Mozart.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.5855"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.166667"
      }
    ],
    "overall_sentiment_score": 0.072922,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "DKNG",
        "relevance_score": "0.238913",
        "ticker_sentiment_score": "-0.136563",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MCQEF",
        "relevance_score": "0.160633",
        "ticker_sentiment_score": "0.180271",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "C",
        "relevance_score": "0.160633",
        "ticker_sentiment_score": "-0.101651",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "D",
        "relevance_score": "0.160633",
        "ticker_sentiment_score": "-0.024533",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GS",
        "relevance_score": "0.160633",
        "ticker_sentiment_score": "-0.101651",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IQV",
        "relevance_score": "0.238913",
        "ticker_sentiment_score": "0.071161",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LEN",
        "relevance_score": "0.238913",
        "ticker_sentiment_score": "-0.057207",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.160633",
        "ticker_sentiment_score": "-0.042506",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LRCX",
        "relevance_score": "0.238913",
        "ticker_sentiment_score": "-0.136563",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.238913",
        "ticker_sentiment_score": "-0.051568",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RBLX",
        "relevance_score": "0.238913",
        "ticker_sentiment_score": "0.240498",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "HD",
        "relevance_score": "0.238913",
        "ticker_sentiment_score": "0.174532",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MRNA",
        "relevance_score": "0.238913",
        "ticker_sentiment_score": "0.003812",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NET",
        "relevance_score": "0.160633",
        "ticker_sentiment_score": "-0.027334",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Animal Health Firm Zoetis Clocks Strong Q2 Earnings, Companion Animal Operations Boost Confidence For 2024 - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/08/40197088/animal-health-firm-zoetis-clocks-strong-q2-earnings-companion-animal-operations-boo",
    "time_published": "20240806T170057",
    "authors": [
      "Vandana Singh"
    ],
    "summary": "On Tuesday, Zoetis Inc ZTS stock is trading higher after the company reported better-than-expected second-quarter financial results and raised its 2024 guidance above estimates.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/08/06/pets-gb3aed6be4-1920.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.990893"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      }
    ],
    "overall_sentiment_score": 0.278203,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.469744",
        "ticker_sentiment_score": "0.398189",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Zoetis  ( ZTS )  Q2 2024 Earnings Call Transcript",
    "url": "https://www.fool.com/earnings/call-transcripts/2024/08/06/zoetis-zts-q2-2024-earnings-call-transcript/",
    "time_published": "20240806T154515",
    "authors": [
      "Motley Fool Transcribing"
    ],
    "summary": "ZTS earnings call for the period ending June 30, 2024.",
    "banner_image": "https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "1.0"
      },
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.341684,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.017812",
        "ticker_sentiment_score": "0.179333",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BCS",
        "relevance_score": "0.004453",
        "ticker_sentiment_score": "0.228822",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "EQIX",
        "relevance_score": "0.004453",
        "ticker_sentiment_score": "0.211864",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BAC",
        "relevance_score": "0.004453",
        "ticker_sentiment_score": "0.228822",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MS",
        "relevance_score": "0.004453",
        "ticker_sentiment_score": "0.228822",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Why Zoetis Stock Was Moving Higher Tuesday",
    "url": "https://www.fool.com/investing/2024/08/06/why-zoetis-stock-was-moving-higher-tuesday/",
    "time_published": "20240806T153348",
    "authors": [
      "Jeremy Bowman"
    ],
    "summary": "It was a classic beat-and-raise quarter for Zoetis.",
    "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F786109%2Fdogecoin-shiba-inu.jpg&op=resize&w=700",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.997335"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.389928,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.614086",
        "ticker_sentiment_score": "0.534109",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Zoetis  ( ZTS )  Q2 Earnings & Revenues Beat, '24 Outlook Raised",
    "url": "https://www.zacks.com/stock/news/2317203/zoetis-zts-q2-earnings-revenues-beat-24-outlook-raised",
    "time_published": "20240806T144300",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Zoetis (ZTS) reports better-than-expected Q2 results, beating both earnings and revenue estimates, primarily driven by strong sales of companion animal products. Management raises the 2024 outlook.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/a7/2964.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999756"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.154599,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.524949",
        "ticker_sentiment_score": "0.377039",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "AKRO",
        "relevance_score": "0.188193",
        "ticker_sentiment_score": "0.106456",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ANIX",
        "relevance_score": "0.279015",
        "ticker_sentiment_score": "0.03781",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ANVS",
        "relevance_score": "0.188193",
        "ticker_sentiment_score": "-0.026527",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Tech Giants Lead Market Selloff",
    "url": "https://www.zacks.com/stock/news/2317119/tech-giants-lead-market-selloff",
    "time_published": "20240806T142400",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Tech Giants Lead Market ...",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f6/47493.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.25"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.451494"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.938793"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.983605"
      }
    ],
    "overall_sentiment_score": -0.050532,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "YUM",
        "relevance_score": "0.140896",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.140896",
        "ticker_sentiment_score": "0.057062",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DUK",
        "relevance_score": "0.140896",
        "ticker_sentiment_score": "-0.021332",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CAT",
        "relevance_score": "0.140896",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FOREX:JPY",
        "relevance_score": "0.20997",
        "ticker_sentiment_score": "0.0969",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "U.S. Stock Futures in Green After Three Days of Devastation",
    "url": "https://www.zacks.com/stock/news/2317106/us-stock-futures-in-green-after-three-days-of-devastation",
    "time_published": "20240806T141500",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "U.S. stock futures are trying to crawl back to normalcy after three days of mayhem. Although the meltdown was predominantly led by technology behemoths, especially AI giants, other sectors have also borne the brunt.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/91/454.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.25"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.451494"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.938793"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.998626"
      }
    ],
    "overall_sentiment_score": -0.048009,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "YUM",
        "relevance_score": "0.197951",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.197951",
        "ticker_sentiment_score": "0.058717",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DUK",
        "relevance_score": "0.197951",
        "ticker_sentiment_score": "-0.022004",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CAT",
        "relevance_score": "0.197951",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FOREX:JPY",
        "relevance_score": "0.197951",
        "ticker_sentiment_score": "0.092623",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Zoetis  ( ZTS )  Tops Q2 Earnings and Revenue Estimates",
    "url": "https://www.zacks.com/stock/news/2316701/zoetis-zts-tops-q2-earnings-and-revenue-estimates",
    "time_published": "20240806T121011",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Zoetis (ZTS) delivered earnings and revenue surprises of 4.70% and 2.53%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default349.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999997"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.157279,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "AMRX",
        "relevance_score": "0.207571",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.401331",
        "ticker_sentiment_score": "0.14587",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Zoetis  ( ZTS )  Just Flashed Golden Cross Signal: Do You Buy?",
    "url": "https://www.zacks.com/stock/news/2317946/zoetis-zts-just-flashed-golden-cross-signal-do-you-buy",
    "time_published": "20240807T133506",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default220.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.315611,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.804667",
        "ticker_sentiment_score": "0.550444",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Zoetis  ( ZTS )  Just Overtook the 50-Day Moving Average",
    "url": "https://www.zacks.com/stock/news/2317986/zoetis-zts-just-overtook-the-50-day-moving-average",
    "time_published": "20240807T133005",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Should investors be excited or worried when a stock crosses above the 50-Day simple moving average?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default90.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.309191,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.815635",
        "ticker_sentiment_score": "0.430911",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Zoetis  ( ZTS )  Just Reclaimed the 200-Day Moving Average",
    "url": "https://www.zacks.com/stock/news/2317990/zoetis-zts-just-reclaimed-the-200-day-moving-average",
    "time_published": "20240807T133002",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Should investors be excited or worried when a stock crosses above the 200-day simple moving average?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default256.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.318971,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.804025",
        "ticker_sentiment_score": "0.705373",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Veterinary Diagnostic Market: $3.3B to $5.0B Growth Forecast  ( 2023-2029 )  | MarketsandMarkets\u2122",
    "url": "https://www.benzinga.com/pressreleases/24/08/g40218842/veterinary-diagnostic-market-3-3b-to-5-0b-growth-forecast-2023-2029-marketsandmarkets",
    "time_published": "20240807T123000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Chicago, Aug. 07, 2024 ( GLOBE NEWSWIRE ) -- The \"Veterinary Diagnostic Market Size, Share & Trends by Product ( Instrument, Consumable ) , Technology ( Immuno ( ELISA, RIA, Lateral flow ) , Molecular ( PCR, Microarray ) , Hematology, Imaging ) , Distribution Channel, End User, Unmet Need, ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.218596,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.09539",
        "ticker_sentiment_score": "0.109914",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IDXX",
        "relevance_score": "0.063678",
        "ticker_sentiment_score": "0.088293",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.063678",
        "ticker_sentiment_score": "0.131267",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio",
    "url": "https://www.zacks.com/stock/news/2319208/why-this-1-growth-stock-could-be-a-great-addition-to-your-portfolio",
    "time_published": "20240808T134510",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default17.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.890401"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.796627"
      }
    ],
    "overall_sentiment_score": 0.369043,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.558244",
        "ticker_sentiment_score": "0.244633",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Here's How Much $100 Invested In Zoetis 10 Years Ago Would Be Worth Today - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/insights/news/24/08/40322008/heres-how-much-100-invested-in-zoetis-10-years-ago-would-be-worth-today",
    "time_published": "20240812T190017",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Zoetis ZTS has outperformed the market over the past 10 years by 7.78% on an annualized basis producing an average annual return of 18.17%. Currently, Zoetis has a market capitalization of $83.03 billion.",
    "banner_image": "https://www.benzinga.com/files/images/story/2024/1723489214_0.png",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.238974,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.95919",
        "ticker_sentiment_score": "0.384695",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "How Is The Market Feeling About Zoetis? - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/insights/short-sellers/24/08/40426035/how-is-the-market-feeling-about-zoetis",
    "time_published": "20240816T204523",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Zoetis's ZTS short percent of float has fallen 11.21% since its last report. The company recently reported that it has 4.65 million shares sold short, which is 1.03% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.45 days to cover their ...",
    "banner_image": "https://www.benzinga.com/files/images/story/2024/1723841121_0.png",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.264538,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.212115",
        "ticker_sentiment_score": "0.081887",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Animal Genetics Market Size is Expected to Achieve USD 17.1 Billion Value by 2034, Fueled by Rising Demand for Protein-Rich Diets | Transparency Market Research",
    "url": "https://www.benzinga.com/pressreleases/24/08/g40438687/animal-genetics-market-size-is-expected-to-achieve-usd-17-1-billion-value-by-2034-fueled-by-rising",
    "time_published": "20240819T123000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Transparency Market Research, Inc. , Aug. 19, 2024 ( GLOBE NEWSWIRE ) -- As per the latest report published by Transparency Market Research ( TMR ) , the global Animal Genetics Market ( Markt f\u00fcr Tiergenetik ) is estimated to reach US$ 17.1 Billion by 2034 at ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/2de6a335-a8dc-4c51-968d-4ed915903116/animal-genetics-market.jpg",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.240327,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.10607",
        "ticker_sentiment_score": "0.096215",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GOOG",
        "relevance_score": "0.03545",
        "ticker_sentiment_score": "0.048287",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GENSF",
        "relevance_score": "0.03545",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NEOG",
        "relevance_score": "0.03545",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GENE",
        "relevance_score": "0.03545",
        "ticker_sentiment_score": "0.167548",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.10607",
        "ticker_sentiment_score": "0.054219",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Here's How Much $100 Invested In Zoetis 10 Years Ago Would Be Worth Today - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/insights/news/24/08/40532215/heres-how-much-100-invested-in-zoetis-10-years-ago-would-be-worth-today",
    "time_published": "20240823T163113",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Zoetis ZTS has outperformed the market over the past 10 years by 6.91% on an annualized basis producing an average annual return of 17.73%. Currently, Zoetis has a market capitalization of $82.47 billion.",
    "banner_image": "https://www.benzinga.com/files/images/story/2024/1724430670_0.png",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.238974,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.95919",
        "ticker_sentiment_score": "0.384695",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "SDZNY or ZTS: Which Is the Better Value Stock Right Now?",
    "url": "https://www.zacks.com/stock/news/2328400/sdzny-or-zts-which-is-the-better-value-stock-right-now",
    "time_published": "20240828T154010",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "SDZNY vs. ZTS: Which Stock Is the Better Value Option?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default359.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.495866"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.481951,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.686739",
        "ticker_sentiment_score": "0.531248",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Phibro Q4 Earnings and Revenues Beat, Operating Margin Down - Quest Diagnostics  ( NYSE:DGX ) , Intuitive Surgical  ( NASDAQ:ISRG ) ",
    "url": "https://www.benzinga.com/news/earnings/24/08/40626343/phibro-q4-earnings-and-revenues-beat-operating-margin-down",
    "time_published": "20240829T172758",
    "authors": [
      "Zacks"
    ],
    "summary": "Phibro Animal Health PAHC delivered adjusted earnings per share of 41 cents in the fourth quarter of fiscal 2024, up 7.9% from the year-ago quarter's level. The bottom line beat the Zacks Consensus Estimate by 20.6%. Without adjustments, the GAAP EPS in the quarter was 2 cents, down 92.9% from ...",
    "banner_image": "https://staticx-tuner.zacks.com/images/charts/9c/1724935133.png",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999998"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.684621"
      }
    ],
    "overall_sentiment_score": 0.103449,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.043186",
        "ticker_sentiment_score": "0.129564",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PAHC",
        "relevance_score": "0.129052",
        "ticker_sentiment_score": "-0.015439",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMDX",
        "relevance_score": "0.129052",
        "ticker_sentiment_score": "0.091146",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DGX",
        "relevance_score": "0.171485",
        "ticker_sentiment_score": "0.074507",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.213423",
        "ticker_sentiment_score": "0.139733",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Phibro Q4 Earnings and Revenues Beat, Operating Margin Down",
    "url": "https://www.zacks.com/stock/news/2328933/phibro-q4-earnings-and-revenues-beat-operating-margin-down",
    "time_published": "20240829T124500",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "PAHC's impressive fourth-quarter fiscal 2024 results can be attributed to the Animal Health segment's robust performance.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/34/73549.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.538269"
      }
    ],
    "overall_sentiment_score": 0.068174,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.043979",
        "ticker_sentiment_score": "0.129803",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PAHC",
        "relevance_score": "0.217249",
        "ticker_sentiment_score": "-0.020129",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMDX",
        "relevance_score": "0.174587",
        "ticker_sentiment_score": "0.09368",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DGX",
        "relevance_score": "0.174587",
        "ticker_sentiment_score": "0.064228",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.217249",
        "ticker_sentiment_score": "0.108732",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Should You Invest in the VanEck Agribusiness ETF  ( MOO ) ?",
    "url": "https://www.zacks.com/stock/news/2330058/should-you-invest-in-the-vaneck-agribusiness-etf-moo",
    "time_published": "20240902T102006",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Sector ETF report for MOO ...",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default254.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.999998"
      }
    ],
    "overall_sentiment_score": 0.170545,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.142144",
        "ticker_sentiment_score": "0.073627",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DE",
        "relevance_score": "0.142144",
        "ticker_sentiment_score": "0.073627",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CTVA",
        "relevance_score": "0.142144",
        "ticker_sentiment_score": "0.073627",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Jim Cramer Says This Retailer Yields 3%: 'Which Is Quite Good' - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/trading-ideas/long-ideas/24/09/40706716/jim-cramer-says-this-retailer-yields-3-which-is-quite-good",
    "time_published": "20240904T124414",
    "authors": [
      "Avi Kapoor"
    ],
    "summary": "On CNBC's \"Mad Money Lightning Round,\" Jim Cramer said Target Corporation TGT reported a \"very, very good\" quarter. \"It does yield 3%, which is actually quite good,\" he added.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/09/04/JimCramer-Shutterstock.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.684621"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.938238"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.25"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      }
    ],
    "overall_sentiment_score": 0.269237,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "TGT",
        "relevance_score": "0.53784",
        "ticker_sentiment_score": "0.454688",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.231332",
        "ticker_sentiment_score": "0.233657",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PRCT",
        "relevance_score": "0.443626",
        "ticker_sentiment_score": "0.064654",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ED",
        "relevance_score": "0.443626",
        "ticker_sentiment_score": "0.235064",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Why Is Zoetis  ( ZTS )  Up 1.4% Since Last Earnings Report?",
    "url": "https://www.zacks.com/stock/news/2332226/why-is-zoetis-zts-up-14-since-last-earnings-report",
    "time_published": "20240905T153121",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Zoetis (ZTS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default172.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.995869"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.152007,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.441912",
        "ticker_sentiment_score": "0.234804",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "IONS",
        "relevance_score": "0.20537",
        "ticker_sentiment_score": "0.028633",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Here's How Much You Would Have Made Owning Zoetis Stock In The Last 10 Years - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/insights/news/24/09/40732010/heres-how-much-you-would-have-made-owning-zoetis-stock-in-the-last-10-years",
    "time_published": "20240905T140028",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Zoetis ZTS has outperformed the market over the past 10 years by 7.14% on an annualized basis producing an average annual return of 17.81%. Currently, Zoetis has a market capitalization of $83.85 billion.",
    "banner_image": "https://www.benzinga.com/files/images/story/2024/1725544824_0.png",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.238974,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.95919",
        "ticker_sentiment_score": "0.384695",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Anthelmintic Drugs Market Projected Growth at 3.9% CAGR to Reach USD 3.7 billion by 2031 | Exclusive Research Report by Transparency Market Research Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/09/g40725223/anthelmintic-drugs-market-projected-growth-at-3-9-cagr-to-reach-usd-3-7-billion-by-2031-exclusive-",
    "time_published": "20240905T095900",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Transparency Market Research Inc. -, Sept. 05, 2024 ( GLOBE NEWSWIRE ) -- As per the report published by Transparency Market Research, the anthelmintic drugs market ( \uad6c\ucda9\uc81c \uc2dc\uc7a5 ) was worth US$ 2.6 Bn in 2022 and is expected to reach US$ 3.7 Bn by the year 2031 ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/05daa975-7257-4177-99b3-a7ae96c4d2a9/anthelmintic-drugs-market.jpg",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.060655,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "GOOG",
        "relevance_score": "0.037563",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BAYZF",
        "relevance_score": "0.037563",
        "ticker_sentiment_score": "0.044869",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.037563",
        "ticker_sentiment_score": "0.044869",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.037563",
        "ticker_sentiment_score": "0.044869",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVS",
        "relevance_score": "0.037563",
        "ticker_sentiment_score": "0.044869",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AMRX",
        "relevance_score": "0.037563",
        "ticker_sentiment_score": "0.044869",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.112357",
        "ticker_sentiment_score": "0.070902",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Zoetis  ( ZTS )  Rises Yet Lags Behind Market: Some Facts Worth Knowing",
    "url": "https://www.zacks.com/stock/news/2336177/zoetis-zts-rises-yet-lags-behind-market-some-facts-worth-knowing",
    "time_published": "20240913T221508",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "In the most recent trading session, Zoetis (ZTS) closed at $191.09, indicating a +0.2% shift from the previous trading day.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default24.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.99246"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      }
    ],
    "overall_sentiment_score": 0.245282,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.549988",
        "ticker_sentiment_score": "0.329873",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "SDZNY vs. ZTS: Which Stock Is the Better Value Option?",
    "url": "https://www.zacks.com/stock/news/2336002/sdzny-vs-zts-which-stock-is-the-better-value-option",
    "time_published": "20240913T154010",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Investors with an interest in Medical - Drugs stocks have likely encountered both Sandoz Group AG Sponsored ADR ( SDZNY Quick QuoteSDZNY - ) and Zoetis ( ZTS Quick QuoteZTS - ) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default213.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.714479"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.485576,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.672712",
        "ticker_sentiment_score": "0.540374",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "PAHC Stock Gains From Innovation, Market Expansion Goal",
    "url": "https://www.zacks.com/stock/news/2335961/pahc-stock-gains-from-innovation-market-expansion-goal",
    "time_published": "20240913T150200",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Phibro Animal Health's nutritional product offerings, such as OmniGen-AF and Animate, are being increasingly used in the global dairy industry.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/3c/2723.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.9545"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.796627"
      }
    ],
    "overall_sentiment_score": 0.297458,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "AXGN",
        "relevance_score": "0.108958",
        "ticker_sentiment_score": "0.057677",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.054607",
        "ticker_sentiment_score": "0.151828",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PAHC",
        "relevance_score": "0.162802",
        "ticker_sentiment_score": "0.281674",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.108958",
        "ticker_sentiment_score": "0.057677",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Is Phibro Stock Worth Retaining in Your Portfolio Now?",
    "url": "https://www.zacks.com/stock/news/2337397/is-phibro-stock-worth-retaining-in-your-portfolio-now",
    "time_published": "20240917T162300",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "PAHC Animal Health business, supported by the flourishing vaccine product line, drives optimism for future growth. However, macroeconomic impacts are a concern.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f5/284.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.99237"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.291747,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.099066",
        "ticker_sentiment_score": "0.240929",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PAHC",
        "relevance_score": "0.148121",
        "ticker_sentiment_score": "0.235174",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.148121",
        "ticker_sentiment_score": "0.123436",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.19661",
        "ticker_sentiment_score": "0.149527",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Zoetis Stock Rises 15% in 3 Months: Time to Add to Your Portfolio?",
    "url": "https://www.zacks.com/stock/news/2338079/zoetis-stock-rises-15-in-3-months-time-to-add-to-your-portfolio",
    "time_published": "20240918T150800",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "ZTS' innovative pet care products, along with efforts to expand the business, are expected to fuel significant growth in the future.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/a7/2964.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.997874"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.320533,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.654681",
        "ticker_sentiment_score": "0.468241",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "KRYS",
        "relevance_score": "0.157483",
        "ticker_sentiment_score": "0.108403",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ILMN",
        "relevance_score": "0.118452",
        "ticker_sentiment_score": "0.121704",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FULC",
        "relevance_score": "0.157483",
        "ticker_sentiment_score": "0.017768",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Starbucks To Rally More Than 22%? Here Are 10 Top Analyst Forecasts For Wednesday - Starbucks  ( NASDAQ:SBUX ) ",
    "url": "https://www.benzinga.com/news/24/09/40919037/starbucks-to-rally-more-than-22-here-are-10-top-analyst-forecasts-for-wednesday",
    "time_published": "20240918T130646",
    "authors": [
      "Avi Kapoor"
    ],
    "summary": "Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Piper Sandler raised the price target for Aspen Technology, Inc. AZPN from $200 to $217.",
    "banner_image": "https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/18090157/image-141-1024x526.png",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.999982"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.166667"
      }
    ],
    "overall_sentiment_score": 0.18931,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BDC",
        "relevance_score": "0.223522",
        "ticker_sentiment_score": "0.295591",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "FERG",
        "relevance_score": "0.223522",
        "ticker_sentiment_score": "0.303672",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SBUX",
        "relevance_score": "0.294977",
        "ticker_sentiment_score": "0.129538",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.223522",
        "ticker_sentiment_score": "-0.031499",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AZPN",
        "relevance_score": "0.223522",
        "ticker_sentiment_score": "0.193504",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "NMIH",
        "relevance_score": "0.223522",
        "ticker_sentiment_score": "0.180597",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PGR",
        "relevance_score": "0.223522",
        "ticker_sentiment_score": "0.099408",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FDX",
        "relevance_score": "0.223522",
        "ticker_sentiment_score": "-0.034911",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GS",
        "relevance_score": "0.150122",
        "ticker_sentiment_score": "0.074722",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LBPH",
        "relevance_score": "0.223522",
        "ticker_sentiment_score": "-0.031325",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WDAY",
        "relevance_score": "0.223522",
        "ticker_sentiment_score": "-0.129575",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Corcept Moves 6.5% Higher: Will This Strength Last? - Corcept Therapeutics  ( NASDAQ:CORT ) , Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/news/earnings/24/09/40938268/corcept-moves-6-5-higher-will-this-strength-last",
    "time_published": "20240919T193639",
    "authors": [
      "Zacks"
    ],
    "summary": "Corcept Therapeutics CORT shares soared 6.5% in the last trading session to close at $42.27. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 15.7% gain over the past four weeks.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/09/19/ani-kolleshi-7jjnj-qa9fy-unsplash.jpg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.972476"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.295832,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.474958",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CORT",
        "relevance_score": "0.297061",
        "ticker_sentiment_score": "0.267075",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Corcept  ( CORT )  Moves 6.5% Higher: Will This Strength Last?",
    "url": "https://www.zacks.com/stock/news/2338319/corcept-cort-moves-65-higher-will-this-strength-last",
    "time_published": "20240919T115300",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Corcept (CORT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default154.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.972476"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.316726"
      }
    ],
    "overall_sentiment_score": 0.25563,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.520773",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CORT",
        "relevance_score": "0.328819",
        "ticker_sentiment_score": "0.27922",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Elanco's Dermatology Treatment Secures FDA Approval For Itchy Dogs, Analyst Highlights Label Warnings And Efficacy - Elanco Animal Health  ( NYSE:ELAN ) ",
    "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40959456/elancos-dermatology-treatment-secures-fda-approval-for-itchy-dogs-analyst-highlight",
    "time_published": "20240920T143509",
    "authors": [
      "Vandana Singh"
    ],
    "summary": "On Thursday, the FDA approved Elanco Animal Health Incorporated's ELAN Zenrelia, a once-daily oral JAK inhibitor for the control of pruritus ( itching ) associated with allergic dermatitis and atopic dermatitis in dogs at least 12 months of age.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/09/20/Cooked-Chicken.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.012146,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ELAN",
        "relevance_score": "0.265859",
        "ticker_sentiment_score": "-0.201228",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.179121",
        "ticker_sentiment_score": "0.047855",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Canadian Animal Health Institute 2024 World Rabies Day Webinar: Event to feature leading experts on cross-border changes to pet travel, wildlife monitoring, and One Health strategies for rabies surveillance and control",
    "url": "https://www.benzinga.com/pressreleases/24/09/g40985322/canadian-animal-health-institute-2024-world-rabies-day-webinar-event-to-feature-leading-experts-on",
    "time_published": "20240923T160000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "TORONTO, Sept. 23, 2024 ( GLOBE NEWSWIRE ) -- The Canadian Animal Health Institute ( CAHI ) is excited to announce its 2024 World Rabies Day Webinar, happening on September 27, 2024.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.188228,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.102449",
        "ticker_sentiment_score": "0.195562",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CEVA",
        "relevance_score": "0.102449",
        "ticker_sentiment_score": "0.195562",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "If You Invested $1000 in Zoetis a Decade Ago, This is How Much It'd Be Worth Now",
    "url": "https://www.zacks.com/stock/news/2341043/if-you-invested-1000-in-zoetis-a-decade-ago-this-is-how-much-itd-be-worth-now",
    "time_published": "20240925T123003",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Holding on to popular or trending stocks for the long-term can make your portfolio a winner.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default119.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.495866"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.259785,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.805613",
        "ticker_sentiment_score": "0.389638",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Buy These 4 S&P 500 Year-to-Date Laggards With Solid Near-Term Upside",
    "url": "https://www.zacks.com/stock/news/2342495/buy-these-4-sp-500-year-to-date-laggards-with-solid-near-term-upside",
    "time_published": "20240927T120700",
    "authors": [
      "Nalak Das"
    ],
    "summary": "Four S&P 500 laggards of this year have double-digit upside left for the rest of 2024. These are: CCL, PFE, ZTS, TDY.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/b9/69037.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.972756"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.999998"
      }
    ],
    "overall_sentiment_score": 0.201831,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "TDY",
        "relevance_score": "0.307924",
        "ticker_sentiment_score": "0.328533",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.307924",
        "ticker_sentiment_score": "0.18398",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PFE",
        "relevance_score": "0.233556",
        "ticker_sentiment_score": "0.099903",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "$1000 Invested In Zoetis 10 Years Ago Would Be Worth This Much Today - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/insights/news/24/09/41098143/1000-invested-in-zoetis-10-years-ago-would-be-worth-this-much-today",
    "time_published": "20240930T160027",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Zoetis ZTS has outperformed the market over the past 10 years by 6.65% on an annualized basis producing an average annual return of 18.1%. Currently, Zoetis has a market capitalization of $88.26 billion.",
    "banner_image": "https://www.benzinga.com/files/images/story/2024/1727712024_0.png",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.238974,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.95919",
        "ticker_sentiment_score": "0.384695",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "SDZNY or ZTS: Which Is the Better Value Stock Right Now?",
    "url": "https://www.zacks.com/stock/news/2343524/sdzny-or-zts-which-is-the-better-value-stock-right-now",
    "time_published": "20240930T154014",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "SDZNY vs. ZTS: Which Stock Is the Better Value Option?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default304.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.838487"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.518484,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.628473",
        "ticker_sentiment_score": "0.574515",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Here's How Much $1000 Invested In Zoetis 10 Years Ago Would Be Worth Today - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/insights/news/24/10/41319573/heres-how-much-1000-invested-in-zoetis-10-years-ago-would-be-worth-today",
    "time_published": "20241014T190021",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Zoetis ZTS has outperformed the market over the past 10 years by 6.56% on an annualized basis producing an average annual return of 18.21%. Currently, Zoetis has a market capitalization of $86.12 billion.",
    "banner_image": "https://www.benzinga.com/files/images/story/2024/1728932418_0.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.238974,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.95919",
        "ticker_sentiment_score": "0.384695",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "JAZZ vs. ZTS: Which Stock Is the Better Value Option?",
    "url": "https://www.zacks.com/stock/news/2351641/jazz-vs-zts-which-stock-is-the-better-value-option",
    "time_published": "20241016T154013",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Investors interested in Medical - Drugs stocks are likely familiar with Jazz Pharmaceuticals ( JAZZ Quick QuoteJAZZ - ) and Zoetis ( ZTS Quick QuoteZTS - ) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default353.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.838487"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.504136,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.699089",
        "ticker_sentiment_score": "0.569297",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "JAZZ",
        "relevance_score": "0.804025",
        "ticker_sentiment_score": "0.622888",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Rapid Medical Diagnostic Kits Market to Surpass $26 Billion with 4% CAGR by 2034 | Fact.MR Analysis",
    "url": "https://www.benzinga.com/pressreleases/24/10/g41376663/rapid-medical-diagnostic-kits-market-to-surpass-26-billion-with-4-cagr-by-2034-fact-mr-analysis",
    "time_published": "20241017T110000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Rockville, MD, Oct. 17, 2024 ( GLOBE NEWSWIRE ) -- Fact.MR, a market research and competitive intelligence provider, reveals in its updated research report that the global rapid medical diagnostic kit market is approximated at a size of US$ 17.6 billion in 2024 and is forecasted to increase to ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/71926703-cfde-4fde-85d1-dc027551f7e3/rapid-medical-diagnostic-kit-market.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.358256,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BMXMF",
        "relevance_score": "0.03448",
        "ticker_sentiment_score": "0.091218",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TRIB",
        "relevance_score": "0.03448",
        "ticker_sentiment_score": "0.091218",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.03448",
        "ticker_sentiment_score": "0.091218",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.03448",
        "ticker_sentiment_score": "0.091218",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.03448",
        "ticker_sentiment_score": "0.091218",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BIO",
        "relevance_score": "0.03448",
        "ticker_sentiment_score": "0.091218",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CAH",
        "relevance_score": "0.03448",
        "ticker_sentiment_score": "0.091218",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.03448",
        "ticker_sentiment_score": "0.091218",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Will Zoetis  ( ZTS )  Beat Estimates Again in Its Next Earnings Report?",
    "url": "https://www.zacks.com/stock/news/2354212/will-zoetis-zts-beat-estimates-again-in-its-next-earnings-report",
    "time_published": "20241021T161014",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default56.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999953"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.281567,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.409171",
        "ticker_sentiment_score": "0.397545",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Finding Great Top-Ranked Momentum Stocks to Buy Now",
    "url": "https://www.zacks.com/commentary/2355249/finding-great-top-ranked-momentum-stocks-to-buy-now",
    "time_published": "20241022T183700",
    "authors": [
      "Benjamin Rains"
    ],
    "summary": "The stocks we learn to search for today are top-ranked momentum stocks that might be worth buying to close out October and throughout the last two months of 2024.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/a2/81807.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.986564"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.327478,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MSFT",
        "relevance_score": "0.055492",
        "ticker_sentiment_score": "0.05188",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.055492",
        "ticker_sentiment_score": "0.247983",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PAHC",
        "relevance_score": "0.422366",
        "ticker_sentiment_score": "0.338867",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings",
    "url": "https://www.zacks.com/stock/news/2355573/how-to-boost-your-portfolio-with-top-medical-stocks-set-to-beat-earnings",
    "time_published": "20241023T125011",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default113.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999973"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      }
    ],
    "overall_sentiment_score": 0.357473,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "VRTX",
        "relevance_score": "0.338119",
        "ticker_sentiment_score": "0.269006",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.400265",
        "ticker_sentiment_score": "0.344661",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Ensign Group  ( ENSG )  Q3 Earnings and Revenues Beat Estimates",
    "url": "https://www.zacks.com/stock/news/2357282/ensign-group-ensg-q3-earnings-and-revenues-beat-estimates",
    "time_published": "20241024T214514",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Ensign Group (ENSG) delivered earnings and revenue surprises of 1.46% and 1.66%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default197.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999997"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.175545,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.201244",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ENSG",
        "relevance_score": "0.389889",
        "ticker_sentiment_score": "0.204222",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Why Investors Need to Take Advantage of These 2 Medical Stocks Now",
    "url": "https://www.zacks.com/stock/news/2357552/why-investors-need-to-take-advantage-of-these-2-medical-stocks-now",
    "time_published": "20241025T125011",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default67.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999998"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.352424,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.38588",
        "ticker_sentiment_score": "0.331615",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TCMD",
        "relevance_score": "0.38588",
        "ticker_sentiment_score": "0.336354",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Zoetis  ( ZTS )  Outpaces Stock Market Gains: What You Should Know",
    "url": "https://www.zacks.com/stock/news/2359106/zoetis-zts-outpaces-stock-market-gains-what-you-should-know",
    "time_published": "20241028T221522",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Zoetis (ZTS) closed at $182.76 in the latest trading session, marking a +1.53% move from the prior day.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default131.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.976913"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.232813,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.546745",
        "ticker_sentiment_score": "0.371412",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Zoetis  ( ZTS )  Reports Next Week: Wall Street Expects Earnings Growth",
    "url": "https://www.zacks.com/stock/news/2358696/zoetis-zts-reports-next-week-wall-street-expects-earnings-growth",
    "time_published": "20241028T140108",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Zoetis (ZTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default334.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.165714,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.259727",
        "ticker_sentiment_score": "0.220729",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ARDX",
        "relevance_score": "0.174903",
        "ticker_sentiment_score": "-0.027103",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Earnings Preview: Zevra Therapeutics  ( ZVRA )  Q3 Earnings Expected to Decline",
    "url": "https://www.zacks.com/stock/news/2359573/earnings-preview-zevra-therapeutics-zvra-q3-earnings-expected-to-decline",
    "time_published": "20241029T140113",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Zevra Therapeutics (ZVRA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default132.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.114886,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.174587",
        "ticker_sentiment_score": "0.023955",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZVRA",
        "relevance_score": "0.259267",
        "ticker_sentiment_score": "-0.047778",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Zoetis Gears Up to Report Q3 Earnings: What's in the Offing?",
    "url": "https://www.zacks.com/stock/news/2359684/zoetis-gears-up-to-report-q3-earnings-whats-in-the-offing",
    "time_published": "20241029T133300",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "ZTS' higher companion animal product sales are likely to have driven revenues in third-quarter 2024 in both the United States and International segments.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/a7/2964.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.99489"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.182343,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.601928",
        "ticker_sentiment_score": "0.389533",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "NVO",
        "relevance_score": "0.237204",
        "ticker_sentiment_score": "0.102589",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BIIB",
        "relevance_score": "0.237204",
        "ticker_sentiment_score": "-0.005519",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Gear Up for Zoetis  ( ZTS )  Q3 Earnings: Wall Street Estimates for Key Metrics",
    "url": "https://www.zacks.com/stock/news/2360467/gear-up-for-zoetis-zts-q3-earnings-wall-street-estimates-for-key-metrics",
    "time_published": "20241030T131526",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Besides Wall Street's top -and-bottom-line estimates for Zoetis (ZTS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2024.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default133.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.972476"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.124575,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.362858",
        "ticker_sentiment_score": "0.240636",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "SDZNY or ZTS: Which Is the Better Value Stock Right Now?",
    "url": "https://www.zacks.com/stock/news/2362788/sdzny-or-zts-which-is-the-better-value-stock-right-now",
    "time_published": "20241101T154012",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "SDZNY vs. ZTS: Which Stock Is the Better Value Option?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default51.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.838487"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.478106,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.651499",
        "ticker_sentiment_score": "0.577263",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "PAHC Stock Likely to Gain From Its Latest Acquisition of Zoetis",
    "url": "https://www.zacks.com/stock/news/2362389/pahc-stock-likely-to-gain-from-its-latest-acquisition-of-zoetis",
    "time_published": "20241101T114100",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Phibro successfully acquires Zoetis Inc.'s MFA portfolio and certain water-soluble products.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f5/284.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.999483"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.299917,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "RMD",
        "relevance_score": "0.117774",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.117774",
        "ticker_sentiment_score": "0.216696",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PAHC",
        "relevance_score": "0.232996",
        "ticker_sentiment_score": "0.321475",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "GMED",
        "relevance_score": "0.117774",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.117774",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Zoetis Q3 Earnings Beat, Companion Animal Segment Growth Gives Confidence Into 2025: Analyst - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41722660/zoetis-q3-earnings-beat-companion-animal-segment-growth-gives-confidence-into-2025-",
    "time_published": "20241104T180712",
    "authors": [
      "Vandana Singh"
    ],
    "summary": "On Monday, Zoetis Inc's ZTS third-quarter 2024 adjusted EPS increased 16% year over year to $1.58, beating the consensus of $1.46. The animal health firm reported sales of $2.39 billion, up 11%, beating the consensus of $2.29 billion.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/11/04/pets-gb3aed6be4-1920.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.997902"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.402278,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.595343",
        "ticker_sentiment_score": "0.425542",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Zoetis  ( ZTS )  Q3 2024 Earnings Call Transcript",
    "url": "https://www.fool.com/earnings/call-transcripts/2024/11/04/zoetis-zts-q3-2024-earnings-call-transcript/",
    "time_published": "20241104T173017",
    "authors": [
      "Motley Fool Transcribing"
    ],
    "summary": "ZTS earnings call for the period ending September 30, 2024.",
    "banner_image": "https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.576289"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.998682"
      },
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.315297,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.049545",
        "ticker_sentiment_score": "0.158404",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PAHC",
        "relevance_score": "0.004507",
        "ticker_sentiment_score": "0.178662",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CSLI",
        "relevance_score": "0.004507",
        "ticker_sentiment_score": "0.133956",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BCS",
        "relevance_score": "0.004507",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BAC",
        "relevance_score": "0.004507",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MS",
        "relevance_score": "0.004507",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Zoetis Q3 Earnings & Revenues Beat, '24 Outlook Raised, Stock Up",
    "url": "https://www.zacks.com/stock/news/2363644/zoetis-q3-earnings-revenues-beat-24-outlook-raised-stock-up",
    "time_published": "20241104T170600",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "ZTS stock gains as third-quarter results beat both earnings and revenue estimates, driven by strong product sales. Management raises the 2024 outlook.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/a7/2964.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.998645"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.248384,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ALLO",
        "relevance_score": "0.196212",
        "ticker_sentiment_score": "0.090654",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.543935",
        "ticker_sentiment_score": "0.459036",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Zoetis  ( ZTS )  Q3 Earnings and Revenues Beat Estimates",
    "url": "https://www.zacks.com/stock/news/2363076/zoetis-zts-q3-earnings-and-revenues-beat-estimates",
    "time_published": "20241104T131008",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Zoetis (ZTS) delivered earnings and revenue surprises of 8.22% and 4.44%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default335.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999992"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.150746,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "PSTV",
        "relevance_score": "0.210579",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.406745",
        "ticker_sentiment_score": "0.147248",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Should You Invest in the VanEck Agribusiness ETF  ( MOO ) ?",
    "url": "https://www.zacks.com/stock/news/2362994/should-you-invest-in-the-vaneck-agribusiness-etf-moo",
    "time_published": "20241104T112007",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Sector ETF report for MOO ...",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default50.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.999998"
      }
    ],
    "overall_sentiment_score": 0.170582,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.143415",
        "ticker_sentiment_score": "0.087632",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DE",
        "relevance_score": "0.143415",
        "ticker_sentiment_score": "0.087632",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BAYZF",
        "relevance_score": "0.072",
        "ticker_sentiment_score": "0.071403",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "If You Invested $1000 In This Stock 10 Years Ago, You Would Have $4,400 Today - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/insights/news/24/11/41745215/if-you-invested-1000-in-this-stock-10-years-ago-you-would-have-4-400-today",
    "time_published": "20241105T140051",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Zoetis ZTS has outperformed the market over the past 10 years by 4.08% on an annualized basis producing an average annual return of 14.89%. Currently, Zoetis has a market capitalization of $79.87 billion.",
    "banner_image": "https://www.benzinga.com/files/images/story/2024/1730815248_0.png",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.238974,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.95919",
        "ticker_sentiment_score": "0.384695",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Phibro's Q1 Earnings Top Estimates, Stock Up, Net Sales Surge Y/Y",
    "url": "https://www.zacks.com/stock/news/2366068/phibros-q1-earnings-top-estimates-stock-up-net-sales-surge-yy",
    "time_published": "20241107T132900",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "PAHC delivers strong growth across all its segments in the first quarter of fiscal 2025.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/96/63046.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999998"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.684621"
      }
    ],
    "overall_sentiment_score": 0.145349,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.0864",
        "ticker_sentiment_score": "0.192222",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PAHC",
        "relevance_score": "0.2138",
        "ticker_sentiment_score": "0.115515",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DGX",
        "relevance_score": "0.17179",
        "ticker_sentiment_score": "0.035835",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.17179",
        "ticker_sentiment_score": "0.059161",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.17179",
        "ticker_sentiment_score": "0.124575",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick",
    "url": "https://www.zacks.com/stock/news/2368186/are-you-a-growth-investor-this-1-stock-could-be-the-perfect-pick",
    "time_published": "20241111T144511",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default50.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.928139"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.295207,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.47672",
        "ticker_sentiment_score": "0.22032",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "1 Magnificent S&P 500 Dividend Stock Down 12% to Buy After Its Recent Pullback",
    "url": "https://www.fool.com/investing/2024/11/11/1-magnificent-sp-500-dividend-stock-down-12-to-buy/",
    "time_published": "20241111T144500",
    "authors": [
      "Josh Kohn-Lindquist"
    ],
    "summary": "Zoetis looks like a classic example of a premium business trading at a fair price following its recent dip.",
    "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F796689%2Fgettyimages-1516239450.jpg&op=resize&w=700",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.360215"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.336432,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.765486",
        "ticker_sentiment_score": "0.506764",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "PFE",
        "relevance_score": "0.055751",
        "ticker_sentiment_score": "0.090998",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Have $100,000? Here Are 3 Ways to Grow That Money Into $1 Million for Retirement Savings.",
    "url": "https://www.fool.com/retirement/2024/11/14/have-100000-here-are-3-ways-to-grow-that-money-int/",
    "time_published": "20241114T103000",
    "authors": [
      "Charlene Rhinehart"
    ],
    "summary": "Whether you're starting from scratch or with $100,000, the same smart investing principles still apply.",
    "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F797347%2Fperson-celebrating-success-on-laptop.jpg&op=resize&w=700",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.938793"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.346228,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.061159",
        "ticker_sentiment_score": "0.091006",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.182047",
        "ticker_sentiment_score": "0.103727",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GM",
        "relevance_score": "0.061159",
        "ticker_sentiment_score": "0.091006",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "SDZNY vs. ZTS: Which Stock Should Value Investors Buy Now?",
    "url": "https://www.zacks.com/stock/news/2371703/sdzny-vs-zts-which-stock-should-value-investors-buy-now",
    "time_published": "20241118T164016",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "SDZNY vs. ZTS: Which Stock Is the Better Value Option?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default76.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.890401"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.459126,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.541149",
        "ticker_sentiment_score": "0.4403",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Veterinary Medicine Market Size to Surpass USD 53.47 Billion by 2033 | Straits Research",
    "url": "https://www.benzinga.com/pressreleases/24/11/g42113819/veterinary-medicine-market-size-to-surpass-usd-53-47-billion-by-2033-straits-research",
    "time_published": "20241121T144000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "New York, United States, Nov. 21, 2024 ( GLOBE NEWSWIRE ) -- Veterinary medicine encompasses preventing, treating, managing, and diagnosing animal diseases, disorders, and injuries. It involves animal husbandry, breeding, nutrition research, and product development.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.179803,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.035983",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IDXX",
        "relevance_score": "0.035983",
        "ticker_sentiment_score": "-0.020635",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "META",
        "relevance_score": "0.035983",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CEVA",
        "relevance_score": "0.035983",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Animal Disinfectants Market Growth Accelerates Toward $5.7 Billion by 2029",
    "url": "https://www.benzinga.com/pressreleases/24/11/g42237618/animal-disinfectants-market-growth-accelerates-toward-5-7-billion-by-2029",
    "time_published": "20241129T020000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Delray Beach, FL, Nov. 28, 2024 ( GLOBE NEWSWIRE ) -- The global animal disinfectants market is witnessing robust growth, with an estimated valuation of USD 3.9 billion in 2024 and a projected CAGR of 7.9%, reaching USD 5.7 billion by 2029.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.161647"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.331845,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.057907",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NEOG",
        "relevance_score": "0.22861",
        "ticker_sentiment_score": "0.286041",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SVYSF",
        "relevance_score": "0.057907",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ECL",
        "relevance_score": "0.057907",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "This Autodesk Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Autodesk  ( NASDAQ:ADSK ) , MediciNova  ( NASDAQ:MNOV ) ",
    "url": "https://www.benzinga.com/24/12/42265982/this-autodesk-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-monday",
    "time_published": "20241202T135609",
    "authors": [
      "Avi Kapoor"
    ],
    "summary": "Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. D. Boral Capital analyst Jason Kolbert initiated coverage on MediciNova, Inc.",
    "banner_image": "https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/02085443/image-1-3-1024x544.png",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.233865,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.377142",
        "ticker_sentiment_score": "0.338156",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "VKTX",
        "relevance_score": "0.377142",
        "ticker_sentiment_score": "-0.021106",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MNOV",
        "relevance_score": "0.377142",
        "ticker_sentiment_score": "0.150358",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ADSK",
        "relevance_score": "0.488007",
        "ticker_sentiment_score": "0.28447",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MS",
        "relevance_score": "0.130217",
        "ticker_sentiment_score": "-0.009676",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PRCT",
        "relevance_score": "0.377142",
        "ticker_sentiment_score": "-0.021124",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Reasons to Add Phibro Stock to Your Portfolio Right Now",
    "url": "https://www.zacks.com/stock/news/2377499/reasons-to-add-phibro-stock-to-your-portfolio-right-now",
    "time_published": "20241202T130600",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "PAHC's Animal Health business, along with flourishing Mineral Nutrition and Performance Product businesses, sparks optimism for future growth.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f5/284.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.96136"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.650727"
      }
    ],
    "overall_sentiment_score": 0.279158,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "PEN",
        "relevance_score": "0.19117",
        "ticker_sentiment_score": "0.116897",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.04823",
        "ticker_sentiment_score": "0.108938",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NRHI",
        "relevance_score": "0.04823",
        "ticker_sentiment_score": "0.138774",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PAHC",
        "relevance_score": "0.143987",
        "ticker_sentiment_score": "0.130992",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GMED",
        "relevance_score": "0.143987",
        "ticker_sentiment_score": "0.146364",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HAE",
        "relevance_score": "0.19117",
        "ticker_sentiment_score": "0.138958",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Top Research Reports for Amazon, Stryker & Lam Research",
    "url": "https://www.zacks.com/research-daily/2378107/top-research-reports-for-amazon-stryker-lam-research",
    "time_published": "20241203T212700",
    "authors": [
      "Mark Vickery"
    ],
    "summary": "Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Stryker Corporation (SYK) and Lam Research Corporation (LRCX), as well as a micro-cap stock, ImmuCell Corporation (ICCC).",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/c0/47.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.252793,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ICCC",
        "relevance_score": "0.179121",
        "ticker_sentiment_score": "0.133981",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LRCX",
        "relevance_score": "0.265859",
        "ticker_sentiment_score": "0.160712",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.090134",
        "ticker_sentiment_score": "0.038697",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.265859",
        "ticker_sentiment_score": "-0.077657",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FOREX:AMD",
        "relevance_score": "0.090134",
        "ticker_sentiment_score": "0.331211",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "SDZNY vs. ZTS: Which Stock Is the Better Value Option?",
    "url": "https://www.zacks.com/stock/news/2379069/sdzny-vs-zts-which-stock-is-the-better-value-option",
    "time_published": "20241204T164015",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Investors looking for stocks in the Medical - Drugs sector might want to consider either Sandoz Group AG Sponsored ADR ( SDZNY Quick QuoteSDZNY - ) or Zoetis ( ZTS Quick QuoteZTS - ) . But which of these two companies is the best option for those looking for undervalued stocks?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default233.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.890401"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.459147,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.599092",
        "ticker_sentiment_score": "0.442391",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Zoetis  ( ZTS )  Up 1% Since Last Earnings Report: Can It Continue?",
    "url": "https://www.zacks.com/stock/news/2379010/zoetis-zts-up-1-since-last-earnings-report-can-it-continue",
    "time_published": "20241204T163056",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Zoetis (ZTS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default73.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.995869"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.413559"
      }
    ],
    "overall_sentiment_score": 0.161503,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.431881",
        "ticker_sentiment_score": "0.236785",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CORT",
        "relevance_score": "0.050572",
        "ticker_sentiment_score": "0.061496",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Zacks Initiates Coverage of ImmuCell With Neutral Recommendation",
    "url": "https://www.zacks.com/stock/news/2378666/zacks-initiates-coverage-of-immucell-with-neutral-recommendation",
    "time_published": "20241204T124900",
    "authors": [
      "Urbashi Dutta"
    ],
    "summary": "Discover why Zacks, being the first on Wall Street to initiate the stock coverage, rates ImmuCell as \"Neutral.\" Explore ImmuCell's market leadership, growth prospects and the game-changing potential of its mastitis treatment nearing FDA approval.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/45/26891.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.144248,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ICCC",
        "relevance_score": "0.154951",
        "ticker_sentiment_score": "0.141256",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.077845",
        "ticker_sentiment_score": "-0.084654",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "The Zacks Analyst Blog Highlights Amazon.com, Stryker, Lam Research and ImmuCell",
    "url": "https://www.zacks.com/stock/news/2378592/the-zacks-analyst-blog-highlights-amazoncom-stryker-lam-research-and-immucell",
    "time_published": "20241204T100000",
    "authors": [
      "Zacks Investment Research"
    ],
    "summary": "Amazon.com, Stryker, Lam Research and ImmuCell are included in this Analyst Blog.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/92/486.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.238355,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ICCC",
        "relevance_score": "0.167904",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LRCX",
        "relevance_score": "0.249531",
        "ticker_sentiment_score": "0.06222",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.084423",
        "ticker_sentiment_score": "0.038188",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.249531",
        "ticker_sentiment_score": "-0.185346",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "FOREX:AMD",
        "relevance_score": "0.084423",
        "ticker_sentiment_score": "0.327142",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Why Is Catalent  ( CTLT )  Up 3.2% Since Last Earnings Report?",
    "url": "https://www.zacks.com/stock/news/2379718/why-is-catalent-ctlt-up-32-since-last-earnings-report",
    "time_published": "20241205T163047",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Catalent (CTLT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default298.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.980509"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.980922"
      }
    ],
    "overall_sentiment_score": 0.028671,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.206685",
        "ticker_sentiment_score": "0.024037",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CTLT",
        "relevance_score": "0.487546",
        "ticker_sentiment_score": "0.149205",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Phibro  ( PAHC )  Down 2.5% Since Last Earnings Report: Can It Rebound?",
    "url": "https://www.zacks.com/stock/news/2380401/phibro-pahc-down-25-since-last-earnings-report-can-it-rebound",
    "time_published": "20241206T163123",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Phibro (PAHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default70.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999162"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.980922"
      }
    ],
    "overall_sentiment_score": 0.068319,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "SYK",
        "relevance_score": "0.194632",
        "ticker_sentiment_score": "0.055895",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.04912",
        "ticker_sentiment_score": "-0.000999",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PAHC",
        "relevance_score": "0.098054",
        "ticker_sentiment_score": "0.035258",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today - Zoetis  ( NYSE:ZTS ) ",
    "url": "https://www.benzinga.com/insights/news/24/12/42472759/100-invested-in-this-stock-10-years-ago-would-be-worth-this-much-today",
    "time_published": "20241212T213016",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Zoetis ZTS has outperformed the market over the past 10 years by 4.24% on an annualized basis producing an average annual return of 15.83%. Currently, Zoetis has a market capitalization of $80.69 billion.",
    "banner_image": "https://www.benzinga.com/files/images/story/2024/1734039012_0.png",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.238974,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.95919",
        "ticker_sentiment_score": "0.384695",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "A Once-in-a-Decade Opportunity: 2 Magnificent S&P 500 Stocks Down 37% and 28% to Buy Before 2025",
    "url": "https://www.fool.com/investing/2024/12/13/once-in-a-decade-opportunity-2-magnificent-sp-500/",
    "time_published": "20241213T134500",
    "authors": [
      "Josh Kohn-Lindquist"
    ],
    "summary": "One of my favorite ways to add money to my portfolio is to invest in proven compounders with track records of delivering market-beating results after short-term pullbacks. This idea is especially true when the stocks in question are trading at what could prove to be once-in-a-decade ...",
    "banner_image": "https://media.ycharts.com/charts/763068489158cce7cd0e90010266f7d6.png",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.503496"
      }
    ],
    "overall_sentiment_score": 0.240607,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.450695",
        "ticker_sentiment_score": "0.2868",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "IDXX",
        "relevance_score": "0.095327",
        "ticker_sentiment_score": "0.082556",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "4 Stocks in Focus That Declared Dividend Hikes Amid Market Volatility",
    "url": "https://www.zacks.com/stock/news/2384048/4-stocks-in-focus-that-declared-dividend-hikes-amid-market-volatility",
    "time_published": "20241216T153700",
    "authors": [
      "Ritujay Ghosh"
    ],
    "summary": "Stocks like PCAR, ZTS, AVGO and TGLS recently announced dividend hikes.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/be/54779.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.972193"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.99393"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.576289"
      }
    ],
    "overall_sentiment_score": 0.024004,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.386875",
        "ticker_sentiment_score": "0.078946",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PCAR",
        "relevance_score": "0.425746",
        "ticker_sentiment_score": "0.218251",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "AVGO",
        "relevance_score": "0.346884",
        "ticker_sentiment_score": "0.163906",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TGLS",
        "relevance_score": "0.46341",
        "ticker_sentiment_score": "0.154163",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Poultry Diagnostics Market to Reach US$ 847.6 Million with Growing at 8.5% CAGR by 2034 | Fact.MR Report",
    "url": "https://www.benzinga.com/pressreleases/24/12/g42527134/poultry-diagnostics-market-to-reach-us-847-6-million-with-growing-at-8-5-cagr-by-2034-fact-mr-repo",
    "time_published": "20241217T123000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Rockville, MD, Dec. 17, 2024 ( GLOBE NEWSWIRE ) -- As per this updated research report by Fact.MR, a market research and competitive intelligence provider, the global poultry diagnostics market is approximated at a value of US$ 374.9 million in 2024 and is forecasted to reach US$ 847.6 million ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/cd6da97e-86ea-4c9c-9db5-3912d049f588/poultry-diagnostics-market.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.360215"
      }
    ],
    "overall_sentiment_score": 0.329626,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.077218",
        "ticker_sentiment_score": "0.060686",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IDXX",
        "relevance_score": "0.038655",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "QGEN",
        "relevance_score": "0.038655",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.038655",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "5 Magnificent Dividend Growth Stocks Down 24% to 41% to Buy Before 2025 for a Lifetime of Passive Income",
    "url": "https://www.fool.com/investing/2024/12/19/5-magnificent-dividend-growth-stocks-to-buy-in-202/",
    "time_published": "20241219T094500",
    "authors": [
      "Josh Kohn-Lindquist"
    ],
    "summary": "If you're an investor looking to grow your long-term passive income prospects, the five stocks in this article could be perfect to add to your portfolio before 2025.Whether you prefer high-yield dividend payers like American Tower ( NYSE: AMT ) , The Hershey Company ( NYSE: HSY ) , and Public ...",
    "banner_image": "https://media.ycharts.com/charts/33ee82a02b5bca4f802c505d823cd229.png",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.2"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.2"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.2"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.692272"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.2"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.451494"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.576289"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.2"
      }
    ],
    "overall_sentiment_score": 0.223391,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDLZ",
        "relevance_score": "0.032164",
        "ticker_sentiment_score": "0.079794",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "QSR",
        "relevance_score": "0.032164",
        "ticker_sentiment_score": "0.021879",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "T",
        "relevance_score": "0.032164",
        "ticker_sentiment_score": "0.09127",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "VZ",
        "relevance_score": "0.032164",
        "ticker_sentiment_score": "0.09127",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MTYFF",
        "relevance_score": "0.128135",
        "ticker_sentiment_score": "0.100762",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AMT",
        "relevance_score": "0.222254",
        "ticker_sentiment_score": "0.13329",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MCO",
        "relevance_score": "0.032164",
        "ticker_sentiment_score": "0.088396",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.222254",
        "ticker_sentiment_score": "0.26612",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SPGI",
        "relevance_score": "0.032164",
        "ticker_sentiment_score": "0.088396",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HSY",
        "relevance_score": "0.159781",
        "ticker_sentiment_score": "0.141792",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PSA",
        "relevance_score": "0.19117",
        "ticker_sentiment_score": "0.151401",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Here's Why Zoetis  ( ZTS )  Gained But Lagged the Market Today",
    "url": "https://www.zacks.com/stock/news/2386597/heres-why-zoetis-zts-gained-but-lagged-the-market-today",
    "time_published": "20241220T231510",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Zoetis (ZTS) closed the most recent trading day at $164.84, moving +0.81% from the previous trading session.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default14.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.95493"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.413559"
      }
    ],
    "overall_sentiment_score": 0.198274,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.656549",
        "ticker_sentiment_score": "0.43512",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "SDZNY or ZTS: Which Is the Better Value Stock Right Now?",
    "url": "https://www.zacks.com/stock/news/2386471/sdzny-or-zts-which-is-the-better-value-stock-right-now",
    "time_published": "20241220T164011",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "SDZNY vs. ZTS: Which Stock Is the Better Value Option?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default220.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.838487"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.494864,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZTS",
        "relevance_score": "0.595343",
        "ticker_sentiment_score": "0.55234",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More - Eli Lilly  ( NYSE:LLY ) ",
    "url": "https://www.benzinga.com/24/12/42638844/large-biopharma-lags-market-jp-morgans-2025-outlook-on-eli-lilly-merck-and-more",
    "time_published": "20241222T195134",
    "authors": [
      "Vandana Singh"
    ],
    "summary": "According to JP Morgan, U.S. large-cap biopharma stocks have underperformed the broader market for two consecutive years, with mixed sentiment shaping investor outlook for 2025.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/12/22/Healthcare--Opioid-Epidemic-And-Drug-Abu.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.744043"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.363138,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ELAN",
        "relevance_score": "0.175221",
        "ticker_sentiment_score": "0.195574",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "VTRS",
        "relevance_score": "0.175221",
        "ticker_sentiment_score": "0.345107",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "LLY",
        "relevance_score": "0.175221",
        "ticker_sentiment_score": "0.262117",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.175221",
        "ticker_sentiment_score": "0.195574",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "IDXX",
        "relevance_score": "0.175221",
        "ticker_sentiment_score": "0.195574",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ABBV",
        "relevance_score": "0.175221",
        "ticker_sentiment_score": "0.396574",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "GILD",
        "relevance_score": "0.175221",
        "ticker_sentiment_score": "0.344367",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "REGN",
        "relevance_score": "0.175221",
        "ticker_sentiment_score": "0.217986",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BMY",
        "relevance_score": "0.175221",
        "ticker_sentiment_score": "0.249624",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PRGO",
        "relevance_score": "0.175221",
        "ticker_sentiment_score": "0.345107",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  }
]